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Abstract
Mastitis, the inflammation of the mammary gland, dramatically decreases dairy
industry revenues and milk quality, making improved control and prevention methods a
goal of the industry. Prior research has observed variation in response to experimental
challenge with regards to inflammation indicators, S. uberis concentrations, and the
need for antibiotics. To determine possible causes of the observed variation following
experimental S. uberis intramammary challenge, we performed genome association
analyses (N = 34 – 36 Holstein dairy cows), a linkage analysis, and S. uberis milk
inoculation (N = 21 Holstein dairy cows) trials. Association analyses were done using
Illumina’s BovineSNP50 BeadChip and 10 novel phenotypes developed using S. uberis
challenge data. A total of 52 SNPs were significantly associated (p < 9.34x 10-5) with
our novel phenotypes, with 17 SNPs in regions with prior evidence for mastitis or
mastitis associated traits. Linkage analyses were performed using Haploview on BTA 2
to identify loci in linkage disequilibrium with the IL-8 receptor, CXCR1, which has
demonstrated importance for neutrophil function critical for mastitis clearance. We
determined that CXCR1 is part of two separate haplotype blocks, one that is 13 kb and
the other is 440 kb. Between association and linkage analyses, 44 potential candidate
genes were identified, where the majority have functions related to inflammation/
immunity or gene expression regulation. S. uberis milk inoculation trials were
conducted in aseptic milk collected within 7 days post-calving from clinically healthy
cows with differing CXCR1 haplotype combinations. Milk samples were inoculated with
three strains of S. uberis (UT366, UT387, and UT888) in vitro and growth was
monitored for 10 hours. Both S. uberis strain and CXCR1 haplotype combination
significantly influenced the rate of S. uberis growth in milk (p < 0.0001) suggesting an
inhibitory or permissive factor towards S. uberis growth may exist with concentration
varying dependent on CXCR haplotype concentration. Further investigation of the
identified candidate genes and proteomics analysis of milk factors could identify more
efficient or better genetic selection methods or novel preventative/treatment compounds
to combat S. uberis mastitis.
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Chapter I: Introduction
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Mastitis, the inflammation of the mammary gland, is one of the most devastating
diseases in the dairy industry. Data shows mastitis can affect 20-50% of any herd
causing an increase in cow morbidity and mortality (Wilson et al. 1997). Additionally,
mastitis costs the dairy industry upwards of $2 billion annually (NMC 2005) in the form
of lost profits, treatment costs, decreased milk yield, and additional labor costs (Akers
and Nickerson 2011; Fetrow 2000). Furthermore, mastitis greatly impacts milk quality,
which is observed by a decreased ability to make cheese, decreased shelf life of dairy
products, and decreased palatability of dairy products by consumers (Barbano et al.
1991; Klei et al. 1998; Ma et al. 2000).
Mastitis frequently results from pathogenic bacteria invading the mammary gland.
Once bacteria invade the mammary gland, epithelial cells and resident macrophages
release cytokines which recruit polymorphonuclear neutrophils (PMN) and other
leukocytes to the site of infection (Paape et al. 2003). The recruitment of cytokines
results in a large influx of leukocytes into the milk, where leukocytes are commonly
referred to as somatic cells. Somatic cell counts (SCC), represented as cells/mL, are
routinely monitored by the majority of dairy producers and are used as an indicator for
the level of intramammary infection or mastitis. There are some resident leukocyte
populations in the mammary gland and/or milk (i.e.: macrophages) meaning even when
pathogenic bacteria are not present in the gland, SCC is greater than zero. Industry
standard considers a SCC below 200,000 cells/mL a healthy gland and SCC above
200,000 cells/mL to indicate either subclinical or clinical mastitis (Dohoo et al. 2011;
Schepers et al. 1997; Schukken et al. 2003). Subclinical mastitis is indicated by only an
increase in SCC. Clinical mastitis presents with the hallmarks of inflammation including
redness, swelling, heat, and pain to the touch, accompanied by a reduction in milk
production (NMC 1999). Clinical mastitis also alters milk resulting in flakes, clots,
and/or strings composed of bacteria, immune cells, and immune related proteins to be
present. In severe clinical cases, milk can become yellow, watery, or even bloody.
Mastitis pathogens can be contagious or environmental in nature. Common
control practices utilized on most US dairy farms, have been successful in controlling
most contagious pathogens, however, environmental pathogens are still an issue
especially in regions with high temperatures/humidity. One common environmental
pathogen is Streptococcus uberis. S. uberis is responsible for a high proportion of both
clinical and subclinical mastitis in addition to being commonly isolated during the dry
(non-lactating period) (Bradley et al. 2007; Petrovski et al. 2011; Riekerink et al. 2008;
Verbeke et al. 2014). S. uberis has some unique pathology characteristics that can
make clearing the infection from the mammary gland more problematic. Once S. uberis
enters the mammary gland, it binds lactoferrin, which is a common milk protein (Fang
2

and Oliver 1999). Lactoferrin can then act as a bridging molecule and allow binding of
S. uberis to the mammary epithelial cells (Fang et al. 2000). After binding, S. uberis
then invades the host cells via caveolae dependent endocytosis (Almeida and Oliver
2006; Matthews et al. 1994). Once internalized, S. uberis can exploit host cell
transduction and persist in the cytoplasm for hours (Almeida et al. 2000; Tamilselvam et
al. 2006) effectively evading the host immune system. Additionally, S. uberis is
especially problematic because, while it typically originates as an environmental
pathogen, it can spread throughout the herd in a contagious manner once introduced
(Zadoks 2007). Due to the prevalence and impact of S. uberis mastitis, increased
preventative and control methods are a long standing goal of the industry.
One way the industry has attempted to control mastitis incidence is through
genetic selection. Traditional genetic selection strategies have focused on selecting
sires whose daughters have decreased SCC or more desirable udder traits that help
prevent bacteria entering into the mammary gland (i.e.: tight teat end sphincters) (Rupp
and Boichard 2003; Seykora and McDaniel 1986). However, these have had limited
success. More recent selection strategies utilizing these same phenotypes have
focused on increasing sample sizes and marker density in order to improve
identification of loci of interest (Meredith et al. 2013; Meredith et al. 2012; Schnabel et
al. 2005). Additionally, genome wide association studies (GWAS) have branched into
using clinical mastitis (CM) incidence as a phenotype for selection (Lund et al. 2008;
Sahana et al. 2014; Tiezzi et al. 2015). Unfortunately, success has still been limited
primarily by low heritabilities and further complicated by the 100+ different pathogens
that can cause mastitis, each with its own unique pathology. Thus, the use of pathogen
specific phenotypes could be advantageous for the identification of loci that could serve
to select against particular causative pathogens, but few such studies have been
conducted (Sørensen et al. 2008).
A recent experimental intramammary S. uberis challenge demonstrated that cow
responses with respect to inflammation indicators, S. uberis CFU, and necessity of
antibiotics differed (Siebert 2013). Such varying responses could be used as novel
phenotypes specific to S. uberis mastitis. We hypothesize that using pathogen specific
phenotypes will identify regions of the bovine genome and candidate genes associated
with S. uberis mastitis. Furthermore, the CXCR1 genetic background of the cow
significantly influenced these observed responses (Siebert 2013). CXCR1 is the
membrane bound receptor for the immune mediator IL-8. Prior studies have
demonstrated that CXCR1 is critical for proper neutrophil functions which are critical for
mastitis clearance (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud
and Pighetti 2005). However, other genes could be in linkage disequilibrium (LD) with
3

CXCR1 and be attributing the varying responses observed. To address our
hypothesis, we propose the following three objectives:
Objective 1: Identify loci and candidate genes associated with S. uberis mastitis using
novel phenotypes developed from S. uberis challenge data.
We hypothesize loci linked to the immune response and S. uberis pathology (i.e.:
inflammatory cytokines, lactoferrin) will be associated with the novel S. uberis
phenotypes.
Objective 2: Determine the haplotype block surrounding CXCR1.
We hypothesize other genes within the CXCR1 haplotype block may be contributing
to the variation in response to S. uberis challenge observed because they are in LD
with CXCR1.
Objective 3: Determine if CXCR1 genetic background influences the ability of S. uberis
to grow in aseptic whole milk in vitro.
We hypothesize CXCR1 genetic background will influence the concentration of
factors (i.e.: cellular components, antimicrobial factors, plasminogen, etc.) in milk
that could be inhibitory or permissive to S. uberis growth.
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Mastitis
Mastitis, or mammary gland inflammation, is an ongoing issue for the dairy
industry which results in billions in lost revenues annually (NMC 2005). Losses include
discarded milk from infected cows, decreased milk production from infected cows,
antibiotic treatments, increased labor for treatment of mastitis cows, and replacement of
culled cows (Akers and Nickerson 2011; Fetrow 2000; Jones et al. 1994). Additionally,
mastitis decreases milk quality, where increased mastitis instance decreases the
palatability of dairy products, decreases the shelf life of products, and decreases the
ability to make cheese (Barbano et al. 1991; Klei et al. 1998; Ma et al. 2000). Mastitis is
the defined as the inflammation of the mammary gland, which is often caused by
bacteria invading the gland through the teat end. Once inside the gland, bacteria
encounter host epithelial cells and macrophages which release cytokines that recruit
neutrophils and other leukocytes to the site of infection (Paape et al. 2002a; Paape et
al. 2003; Paape et al. 2002b). This recruitment of leukocytes results in a large influx of
immune cells into the milk, where they are commonly referred to as somatic cells.
Somatic cell counts (SCC) or somatic cell scores (SCS; the log10 of SCC) are routinely
monitored by dairy producers and processors, and are used as an indicator of mastitis.
There are some resident somatic cells in the mammary gland and/or milk (i.e.:
macrophages) meaning even when pathogenic bacteria are not present in the gland,
SCC is greater than zero. Industry standard considers a SCC below 200,000 cells/mL a
healthy gland and SCC above 200,000 cells/mL to indicate mastitis (Dohoo et al. 2011;
Schepers et al. 1997; Schukken et al. 2003). Mastitis can be clinical or subclinical,
where both are hallmarked by an increase in SCC above 200,000 cells/mL, but clinical
mastitis is also indicated by inflammation and altered milk production, as well as
reduced milk production (NMC 1999).
Several factors can influence the probability of a cow getting mastitis including
age, parity, stage of lactation, genetics, breed, herd management, climate, and
causative pathogen. Mastitis incidence increases with parity, or the more offspring a
cows has the more likely it is she will contract mastitis (Ruegg 2003). Stage of lactation
also influences mastitis risk, with dry (non-lactating) cows that are not being regularly
handled/milked and cows in early lactation are more susceptible to developing mastitis
than cows in late lactation (Oliver and Mitchell 1983). Climate can also influence
mastitis incidence, specifically warm and moist climates favor the growth of most
pathogens, which increases their overall numbers in the cow’s environment and
increases the probability that the pathogen comes into contact with the cow and causes
mastitis (Hogan and Smith 1987). The influence of these various factors on mastitis
incidence lead to a high degree of variation observed in mastitis incidence across herds
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and breeds of dairy cattle, where most herds demonstrate a mastitis incidence of 2050% (Wilson et al. 1997).
Mastitis causative pathogens can be environmental or contagious in nature.
Contagious pathogens are transferred from cow to cow. Spread of contagious
pathogens is often facilitated by the milking process where bacteria present on one cow
can be passed on to the next cow via milker’s hands or the milking claw (Hogan and
Smith 1987). Environmental pathogens are those present in the general environment of
the cow (i.e.: soils) and gain entrance to gland via proximity (Hogan and Smith 1987;
Hogan et al. 1989; Smith and Hogan 1993). Common mastitis control and prevention
strategies (i.e.: pre-dips, post-dips, etc.) used on most US dairies have been successful
in controlling most contagious pathogens, but environmental pathogens remain an
issue, particularly in areas with warm and moist climates. Streptococcus uberis is a
common mastitis pathogen that is responsible for a high proportion of both clinical and
subclinical mastitis and is commonly isolated from the dry (non-lactating) period
(Bradley et al. 2007; Jayarao et al. 1999; Oliver 1988; Petrovski et al. 2011; Phuektes et
al. 2001; Riekerink et al. 2008; Verbeke et al. 2014). Furthermore, while S. uberis
originates as an environmental pathogen, it can spread through a herd in a contagious
manner (Zadoks 2007). Thus, control and prevention of mastitis, particularly, S. uberis
mastitis, is a long standing goal of the dairy industry.
Genetic Selection
One method employed to help control and prevent mastitis is genetic selection.
The idea of using genetics in animal breeding to improve the overall health of any given
population by reducing diseases and improving animal performance (i.e.: increasing
milk yield) has been around for decades (Soller and Beckmann 1983). Genetic
selection is the process that makes certain desirable traits more prevalent than other
less-desirable traits within a given population by carefully breeding individuals with the
desired traits to make the next generation. Genetic selection is facilitated by the use of
PTAs (predicted transmitting abilities) or STAs (standard transmitting abilities), are
estimates of the genetic superiority or inferiority that a cow or bull will transmit to their
offspring for given traits (The Holstein Foundation 2015).
PTAs are available for a variety of traits including: milk yield, fat percentage, type
traits (i.e.: traits specific to the breed), udder characteristics, somatic cell score (SCS),
and others, and are often used to rank bulls by their genetic merit. PTAs are calculated
using best linear unbiased predictions (BLUP), which take into account not only the trait
measurements, but also information on pedigree, environment, and relationships
between traits to determine the best prediction of the trait that will be passed on to
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offspring (Campbell and Marshall 1975). PTAs are represented as differences from the
genetic base, or average for that trait specific to breed, and are expressed in units
contingent on the properties of the trait being measured (Wattiaux 1995). Thus,
displaying PTAs for different traits for one individual bull on the same graph would help
to determine if a given bull is an extreme for one trait over others, but is difficult because
of varying units. Standard transmitting abilities (STAs) are determined from PTAs of
linear type traits so that traits are represented on a standardized scale and able to be
depicted on the same graph (The Holstein Foundation 2015). STAs are typically
depicted as within 3 standardized units of zero, positive or negative, where values
closer to zero indicate the bull is more likely to pass on the breed average phenotype for
that trait to its offspring (Holstein Association USA 2013).
Also important when looking at PTAs, is reliability, often expressed as %R.
Reliability refers to the estimated accuracy of the calculated PTA and is a factor of the
amount of information used to calculate the PTA (Wattiaux 1995). Reliability is
influenced by several factors including: reliability of PTA values for parents/other
relatives of the bull, number of records available for that bull’s offspring, and the number
of herds (varying environments) those offspring are located in (Wattiaux 1995). As the
amount of information known about a given sire increases, the reliability of their
calculated PTAs increases. When a calf is born, their PTAs are based solely on the
PTAs of their parents and relatives since the calf does not have offspring yet, which
results in relatively low reliability. The reliability of calf PTAs can be improved using
genomic testing. Genomic testing involves genotyping the calf at many single
nucleotide polymorphisms (SNPs). The resulting genotypes are then compared to a
subset of individuals (i.e.: training population) that have reliable PTAs based on their
offspring and have also been genotyped, in order to determine what components of
PTAs can be attributed to genetics (Wiggans et al. 2011). Based on the comparison, a
selection index is developed that combines the parent/relative PTA information and
genetics to improve the reliability of the calf PTA (The Holstein Foundation 2015;
VanRaden et al. 2009). As the calf ages and has offspring whose phenotypes can be
measured, this information is also included in the PTA calculation, further improving the
reliability since more information is used. Bulls that have 100 daughters in 100 different
herds typically have about 88% reliability without genetic information included (Wattiaux
1995). However, even when information about a bull’s parent/relative PTAs, hundreds
or thousands of daughters, and genetics are included in PTA calculation, the highest
reliability reachable is 99% since the set of genes the daughters receive from the bull is
always random (The Holstein Foundation 2015).
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PTAs (i.e.: genetic selection) have been used to decrease mastitis incidence.
Such selection began with selecting against udder traits that would make bacteria
entrance into the gland easier. Selection against deep udders, long teats, loose udder
attachment, and unbalanced udders were correlated with less mastitis incidence likely
due to reduce proximity of the udder to organic matter on the ground that is heavily
laden with mastitis causing bacteria (Lund et al. 1994; Rupp and Boichard 1999;
Sørensen et al. 2000). Selection efforts against mastitis progressed to selection against
cows with high somatic cell scores (SCS, log10 of SCC). Since somatic cell counts are
used as an indicator of mastitis, where industry standard considers concentrations
above 200,000 cells/mL to indicate mastitis (Dohoo et al. 2011; Schepers et al. 1997;
Schukken et al. 2003), cows with higher average SCS over a lactation would correlate
to cows with frequent mastitis bouts or chronically mastitic cows. More recently, there
has been some selection based on clinical mastitis, but this has been limited to
Scandinavian countries where treatment of clinical mastitis is performed only
veterinarians, which facilitates the record keep process (Heringstad et al. 2003;
Philipsson et al. 1995). Success using these mastitis selection traits has been limited,
likely due to the complexity of the disease and the variation in causative pathogens with
each having unique pathology. Furthermore, complex traits, like SCS, are easily
influenced by other factors including heritability and epistasis.
Heritability
Heritability is defined as the proportion of phenotypic variance attributed to
differences in genotypes (Lush 1949). When attempting to identify causes of
phenotypic differences, the differences are best represented by their variance (i.e.: the
differences squared), and can be broken into two subset definitions (Lush 1949). The
broad sense of heritability is a function of genotype variance divided by phenotype
variance and is used in contrast to the environmental effects. However, this broad
definition (represented as H2) relies on the genotype being transmitted as one unit,
which is unrealistic. Instead, genes that combine to produce a phenotype can
segregate and recombine to generate new combinations. Such recombinations could
cause unique gene interactions resulting in genotype averages that are substantially
different than the average genotype within the general population. Thus, the narrow
sense of heritability (represented as h2) includes only the additive effects or variance of
the genes (the variance attributed to parent-offspring resemblance) divided by the
phenotype variance. The result of narrow heritability is the expected fraction of
phenotypic variation between parents that can be expected to be passed on to the next
generation (Lush 1949).
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The representation of heritability as h2 became popular because of Sewall
Wright’s use of h to represent heredity in describing his path coefficient model. The
path coefficient model describes the correlation squared (i.e.: h2) as the proportion of
phenotype attributed to ‘the path from genotype to phenotype’ (Wright 1920). In
addition, Ronald Fisher described the resemblance among relatives using regression
and correlation coefficients while estimating the variance in phenotype that is attributed
to genotypes as a percentage (Fisher 1919). However, the term heritability is credited
to Jay L. Lush, who used it to describe proportion of variance due to hereditary factors
(Lush 1940). Over the years, statistical methodology in partitioning variation and
estimating heritability has been thoroughly developed and has largely converged across
disciplines and species (Lynch and Walsh 1998). The percentages of variance, first
described by Fisher, have come to correspond to the current definitions of broad- and
narrow-sense heritability (Visscher et al. 2008).
Presently, the equation used to calculate heritability is a ratio of variances. The
numerator is the variation from additive genetic values of a given population or breeding
values, defined as the sum of the parents’ genes average effect that results in a
phenotypic mean value for all the parents’ progeny (Falconer 1975). The denominator
is the total observed variation that has been adjusted to exclude variation attributed to
certain fixed effects (i.e.: sex, age) (Visscher et al. 2008). The result of the heritability
equation is a proportion, represented as a value between 0 and 1, called the heritability
index (HI). The higher the heritability index, the higher the probability of the measured
phenotype being passed on to the next generation through parent genotypes within the
population it was measured.
Heritability estimates are based on observed differences between actual and
expected resemblance between relatives. When selection pressure is applied, the ratio
of the amount of change in the mean phenotype between generations to the difference
in mean phenotype between parents is used to estimate heritability (Visscher et al.
2008). Determined over several generations, the heritability is the regression or ratio of
the cumulative selection response to the cumulative selection differentials (Falconer
1975). Traditionally, heritability was measured using simple balanced designs such as
those involving regressions between offspring and parent phenotypes, correlation of
siblings’ phenotypes, and correlations between twin pairs of monozygotic and dizygotic
origins (Falconer 1975). More recent linear mixed models have allowed for heritability
calculation from more complex designs including those where phenotype information is
available for a variety of relationships, unbalanced designs, and those that include
environmental variances. The ‘animal model’ is one linear mixed model, which was
originally designed for use in animal breeding, where an additive genetic relationship is
14

fitted for each individual in the pedigree and weighted appropriately according to their
sampling variance (Lynch and Walsh 1998; Quaas and Pollak 1980). Estimations of
genetic variance components from complex pedigrees are accomplished using residual
maximum likelihood methodology or Markov chain Monte Carlo methods, with the latter
deriving more conservative Bayesian estimates (Patterson and Thompson 1971;
Sorensen and Gianola 2007). To obtain accurate estimates of heritability, hundreds of
observations are necessary to reduce the sampling error which is contingent on low
sampling variance and controlled by large observation numbers (Falconer 1975).
Considering heritabilities and the variances used to calculate them are
parameters of a given population it is possible only to estimate heritability opposed to
determine a defined value of heritability across populations. This is due to the fact that
hereditability is not merely a factor of genetics and can be influenced by several factors.
The main factor that influences heritability is the environment. In fact, Jacquard (1983)
states that heritability is actually a result of two factors: the genes transmitted to
offspring at the time of conception, and the environmental contribution, in all its forms,
during the entirety of development. Additionally, heritability can be confounded by
factors such as sex, age, and cohort. Thus when determining heritability, these factors
are adjusted for when calculating the variance in phenotype, which is the denominator
of the heritability equation (Visscher et al. 2008). If identifiers for a cofounding factor
are not present, thus not allowing for correction of the cofounding factor, phenotypic
variance calculated will be higher and result in a lower heritability calculation (Visscher
et al. 2008). Another factor that can influence heritability is time. If over time a
selection pressure is applied to a particular phenotype, then the variance of that
phenotype decreases. Decreased phenotype variance results in a higher calculated
heritability such as observed by the increase in first lactation milk yield between the
1970’s and the present day (Berry et al. 2003). The fact that heritability can be
influenced by a variety of factors is supported by the fact that heritabilities calculated for
the same trait in different populations often vary due to the different combined effects of
the environmental factors each population is subjected to (Visscher et al. 2008).
However, heritabilities calculated for the same trait can be very similar to each other
regardless of the population they are measured in.
With respect to artificial insemination programs such as those used within the
dairy industry, heritability is used to speculate the effectiveness of using phenotypic
information to determine breeding value when selecting mating pairs to improve herd
genetics. High heritabilities for traits that are easy to measure (i.e.: milk yield) become
the basis for producers to develop easy and effective breeding schemes that improve
the overall herd over time. However, traits with low heritability (i.e.: somatic cell count)
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are more difficult to develop breeding schemes around since they require analysis of
many related individuals to predict somewhat accurately and can be strongly influenced
by environmental factors like causative pathogen.
Epistasis
Epistasis refers to the interaction of genes that are not alleles and it is thought to
influence many complex traits/diseases such as SCS/mastitis. Selection of
traits/diseases with epistatic influences is more difficult because you need to select for a
collection of genes working together to cause a desired phenotype instead of one gene
causing the phenotype. The term ‘epistatic’ was first used in the early 1900’s to
describe one loci preventing the manifestation of another loci effect, which was seen as
an extension of allele dominance (Bateson and Mendel 1909). Since its first
description, there have been many refinements to the concept of epistasis, which has
resulted in variations in the definition. The original definition is most similar to the
definition used today by biologists where epistasis refers to the effect of one locus on
another, often resulting in the ‘masking’ of one locus in the presence of the other
(Siemiatycki and Thomas 1981). The original definition implies directional epistatic
effects where loci A affects loci B, but not vice versa, whereas, the more modern
definition used by biologists does not imply directionality, making this definition of
epistasis more generalized than the original (Bateson and Mendel 1909; Neuman et al.
1992). In models where epistasis is detected, it is often assumed this has biological
significance about the mechanisms of disease, which may not be the case depending
on how the model itself was composed. There is not always agreement between
statistical and biological models of epistasis and significant statistical interactions do not
imply biological or mechanistic interactions (Witte 2005).
There are many different molecular mechanisms that are theorized to cause
epistasis. First are metabolic models, which describe epistasis between mutations that
affect one target enzyme or a family of enzymes with similar structure and/or function
(de Visser et al. 2011). Because enzymes typically function within a metabolic
network/pathway, the interactions that characterize the network/pathway often dictate
epistatic interactions (Szathmary 1993). In fact, models of yeast pathways have
demonstrated mutations in successive steps of a pathway typically display redundant
epistatic effects, whereas, mutations in unrelated pathways demonstrated varied effects
congruent to the relatedness of the mutated pathways (Segre et al. 2005). Second is
pleiotrophy, where mutations can be affecting multiple phenotypes (de Visser et al.
2011). Pleiotrophy is frequently demonstrated within proteins where one mutation may
increase the activity rate of an enzyme but a subsequent mutation that stabilizes the
same enzyme causes enzyme neutralization or loss of function (DePristo et al. 2005;
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Wang et al. 2002). Third is the environment, where varying environmental conditions
can allow for different and/or novel interactions amongst genetic loci (de Visser et al.
2011). In fact, the degree of environmental complexity is thought to influence the
evolution of epistasis, and can be demonstrated by bacteria showing greater divergence
when subjected to complex environments opposed to simple environments (Cooper and
Lenski 2010; Korona et al. 1994; Rozen et al. 2008). Environmental effects on epistasis
are most easily demonstrated where a mutation results in an inactive/truncated protein
wherein alternative proteins/pathways compensate for the lost function (Crow and
Kimura 1979). Fourth is robustness or the insensitivity of organisms to the effects of a
mutation due to the diversity/complexity of the genome (Visser et al. 2003; Wagner
2013). If the genome consists of overlapping structures and functions, then any one
mutation will have a lower impact since other sequences likely have the same or
overlapping functions (Sanjuán and Elena 2006; Sanjuán and Nebot 2008). Lastly is
evolvability, defined as the ability to adapt quickly to a varying environment, likely due to
mutation/recombination (de Visser et al. 2011). High mutation rates and recombination
can inadvertently select for genetic robustness facilitating the epistatic influences
discussed with robustness (Azevedo et al. 2006; Visser et al. 2003; Wilke et al. 2001).
However, recombination can cause a reduction in epistasis because recombination
selects for ‘generalist’ mutations which benefit an array of genetic backgrounds
opposed to selecting co-adapted complexes (Azevedo et al. 2006; Malmberg 1977). As
previously discussed, variation in mastitis phenotype is heavily influenced by the
environment indicating which could also be influencing the epistatic relationships within
the genome. Thus, allowing for the inclusion of multiple traits in disease modeling will
hopefully allow the identification of genetic variants that may otherwise remain
undetected for complex disease traits such as mastitis.
Genome Wide Association Studies (GWAS)
Genetic selection has had limited success in reducing mastitis by selecting for
more desirable udder characteristics, reduced SCS, and reduced clinical mastitis,
genome likely due to low heritability and potential epistatic effects throughout the
genome. As a result, other methods, including genome wide association studies
(GWAS), have emerged to help improve overall mastitis phenotypes in dairy cows
through genetics. GWAS attempt to identify associations with specific phenotypes and
loci throughout the genome. Such associations could identify causal mutations related
to the phenotype of interest and/or loci in linkage disequilibrium (LD) with causal
mutations. Additionally, GWAS can identify candidate genes, genes that the associated
SNPs are in or near, whose functions can be investigated further to identify their
functional relationship to the associated phenotype.
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Loci Associated with Mastitis Phenotypes
Many studies have utilized the GWAS approach to identify loci associated with
mastitis phenotypes. Pighetti and Elliott (2011) reviewed much of the research
completed before 2011, identifying 10 quantitative trait loci (QTLs) for SCC/SCS located
in similar regions of the genome in more than one study. Since then, several more
studies have been completed which have helped to confirm previously identified QTLs
and identified novel loci associated with mastitis phenotypes. A QTL website
(http://www.animalgenome.org/cgi-bin/QTLdb/BT/index) helps to collect the most recent
information and is updated regularly (Hu et al. 2010). Since 2011, GWAS have
discovered loci associated with mastitis phenotypes on every autosome of the bovine
genome in a variety of breeds and populations. At least half of the loci discussed were
previously identified themselves or overlap with previously identified regions in the same
breed/population and/or new ones. Newer studies take advantage of advances in
statistical methodology and new software releases to help improve prior results or
narrow wide ranges with known associations.
One more recent GWAS utilized two separate populations of Holstein-Friesians,
one of sires and one of cows, to identify associations between daughter yield deviations
(DYD) for SCS, among other economic dairy traits, and the over 50,000 SNPs included
in the medium density BeadChip from Illumina (Meredith et al. 2012). Both single SNP
regression and Bayesian methods were utilized in analysis, where SNPs were included
as continuous variables. Additionally, pedigree information for at least the prior four
generations was included for each animal and accounted for by calculating average
additive relationships between animals to reduce the likelihood of identifying false
positives due to close animal pedigrees (Gilmour et al. 2009). SNP regression analyses
included individual animal effects as random and multiple testing was accounted for by
using false discovery rate reduction (Storey and Tibshirani 2003). The BayesB method
for Bayesian testing was utilized but modified to account for the reliability of DYD
phenotype information (Meuwissen et al. 2001). They identified 9 SNPs associated with
SCS (p<0.05) using a single SNP regression analysis approach including loci on BTAs
6, 10, 15, and 20. Three of the identified SNPs are located in previously identified QTL
regions on BTAs 6 and 10 (Bennewitz et al. 2004; Daetwyler et al. 2008; Rupp and
Boichard 2003). The remaining 6 loci were located in novel regions for SCS association
with the strongest association on BTA 20. However, when a Bayesian analysis was
used in place of a single SNP regression analysis to reduce false discoveries, only one
SNP on BTA 4 was associated with SCS which had been previously identified by (TalStein et al. 2010). The marked reduction in SNP associations with the Bayesian
approach is speculated to be from the decreased reliability of the SCS proofs used to
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develop the SCS DYD phenotypes. Decreased reliability of SCS phenotypes likely
originates from less certainty in the true breeding value of the animal because
environment plays such a heavy role in mastitis incidence for cows.
A second study by Meredith et al. (2013), again utilized Holstein-Friesians to test
associations with SCS and clinical mastitis DYD, that were based on a larger number of
progeny, to test associations with SNPs arrayed on Illumina’s high density BeadChip
with over 777,000 SNPs. P-values were corrected for multiple testing using the
Benjamini-Hochberg procedure (Benjamini and Hochberg 1995) and QTL boundaries
were determined based on pairwise linkage disequilibrium (LD), or the non-random
association of loci due to close proximity, using Plink (Purcell et al. 2007). If the
boundaries of two QTL overlapped, they are combined into one using the
R/Bioconductor package “GenomicRanges” (Aboyoun et al. 2010; Gentleman et al.
2004). Post analysis, a total of 138 significant SNPs were identified across BTA 1, 3, 4,
5, 6, 9, 10, 13, 17, 20, 21, 22, 23, 24, 25, and 26. Eleven of the identified SNPs fell
within known regions of SCS association, leaving 17 novel significant SNPs. In
comparing the results between their two studies, Meredith et al. (2013) noted the SNPs
identified using the high density SNP array (777,000 SNPs) were more strongly
associated and had more defined QTL boundaries than those they identified previously
with the medium density array (54,000 SNPs) (Meredith et al. 2012). In attempts to gain
more information from the prior study, Meredith et al. (2013) performed imputation on
the medium density genotypes with BEAGLE software (Browning and Browning 2009)
using the high density array genotypes as a reference, but results proved unsuccessful
with no consistency of imputation score across data sets and no significant associations
being detected with the combined two data sets from both studies. Speculation was
made that, either the reference array was of insufficient sample size (n=724) or the
variation in the surrounding LD structure of significant SNPs caused the inconsistency
of imputation (de Bakker et al. 2008; Spencer et al. 2009).
Another 2013 study by Sahana et al. (2013), performed a genome wide
association analysis for mastitis traits on Nordic Holsteins using the medium density
array (54,000 SNPs) from Illumina in attempts to confirm and refine the mapped position
of QTLs identified previously using 356 microsatellite markers by Lund et al. (2008).
Before running associations, data mining was completed to remove SNPs with call
scores below 0.65 and minor allele frequencies below 0.05. Additionally, genotypes
missing on the array were imputed using Fast-Phase software (Scheet and Stephens
2006). To determine associations, a mixed model was used where individual SNPs
were added step-wise to the model as fixed effects and the polygenic genetic effect was
a random effect (Yu et al. 2006). A Bonferroni correction was performed to reduce
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family-wise error rate, but was found to be too conservative in correcting p-values (Han
et al. 2009), so instead corrections to reduce false discovery rate as described by
Benjamini & Hochberg (1995) were applied to help reduce the instance of false
positives but not be overly conservative. A total of 143 significant SNP associations
with clinical mastitis phenotypes were identified with the majority on BTAs 6, 14, 16, and
20. Overall, 6 of the identified SNPs (BTA 5, 9, and 24) were within the regions
previously identified as associated with mastitis QTLs, despite the definitions of mastitis
used differing slightly across studies (Lund et al. 2008; Lund et al. 2007; Nilsen et al.
2009; Sahana et al. 2008; Sodeland et al. 2011).
As a follow up to their prior work, Sahana et al. (2014) performed a targeted
association study attempting to fine-map QTL regions previously identified in Nordic
Holsteins for clinical mastitis and SCC (Lund et al. 2008; Lund et al. 2007; Sahana et al.
2013) using sequence level variants and confirm if the same QTL regions existed in
Danish Jerseys or if the two breed populations segregated. Estimated breeding values
from artificial insemination sires for clinical mastitis and SCC traits were associated with
SNPs on a medium density SNP array (54,000 SNPs) from Illumina. Extensive data
mining was performed again pre-association analysis to remove low quality base calls,
keep minor allele frequencies below 5%, and prevent deviation from Hardy-Weinberg
equilibrium, to increase power and reduce false discovery rate. Like other studies,
imputation was also used, but here it was targeted to 9 mastitis and SCC traits in Nordic
Holsteins located on BTAs 5, 6, 13, 16, 19, and 20 using high density array (777,000
SNPs) information. Only SNPs with greater than 0.9 imputation certainty were kept to
perform associations. Following association analysis with Bonferroni multiple testing
corrections, a total of 6 wide-peaked regions of association located on the 6 BTA that
were targeted. In conjunction with regular association tests, association tests with the
most important SNP as a cofactor in the model were also run. These cofactor analyses
resulted in a collapse of the wide peaks of association on all chromosomes, likely
indicating the single genetic variant within the targeted region, except for on BTA 5.
The collapsed peak for each chromosome association likely indicates the causative
single genetic variant for each region, but extensive LD does not allow for eliminating
the possibility of multiple causal variants for the regions. Additionally, loci on BTA 16
and 20 previously identified in Nordic Holsteins were confirmed present in Danish
Jerseys.
Tiezzi et al. (2015) also attempted to identify loci associated with mastitis using
GWAS. They utilized producer reported instance of clinical mastitis on N=103,585
Holsteins associated with their sire’s genotypes using a BovineSNP50 BeadChip from
Illumina. However, they employed a single-step genomic BLUP method that
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incorporated both pedigree and genomics of each animal into a matrix that weighted
each marker’s contribution by the variance of that marker to better account for
relatedness of the animals and the genetic variance demonstrated by the population
measured. Additionally, the binary nature of the clinical mastitis phenotype was
accommodated using a threshold-liability model. This analysis identified 10 genomic
regions that explained significant portions of the variation observed in clinical mastitis
incidence which were located on BTAs 2, 8, 11, 14, 16, 19, 20, and 29, with the most
significance being attributed to the regions on BTA 2, 14, and 20. While other studies
have identified loci associated with clinical mastitis on these chromosomes (Klungland
et al. 2001; Sodeland et al. 2011; Youngerman et al. 2004), only the region identified on
BTA 20 (32.17-61.61) was also identified using a clinical mastitis phenotype by another
study (Sodeland et al. 2011).
Lastly, Biffani et al. (2016) took a novel approach by using a case-control design
to identified loci associated with mastitis. Their approach looked at Italian Holstein cows
that were repeatedly screened for mastitis over time (N=550 with mastitis cases, N=571
without – controls) and compared them to the results of a prior GWAS on SCC breeding
values of Italian Holstein sires. The comparison focused on 9 previously identified
SNPs that are located on BTA 6 and 14 (Minozzi et al. 2011) and was completed using
a single-SNP regression model in the ‘qtscore’ function in the GenABEL package
(Aulchenko et al. 2007) in R. The results agreed with the prior studies finding 2 of the
SNPs on BTA 6 and 4 of the SNPs on BTA 14 significantly associated with mastitis
incidence which validated using historical case-control data for GWAS.
These recent studies focused on confirming and narrowing the loci previously
identified in mastitis trait association studies. Overall, results seemed to favor loci
located on BTA 6, 14, 16, and 20, but loci were identified on every chromosome of the
genome. Bayesian based approaches seems to provide great benefit in reducing false
discoveries, although studies correcting for family wise error rate through pedigrees met
with less success than those correcting for false discovery rates, since the latter is less
abruptly conservative and does not reduce power as heavily as the former. Studies
utilizing imputation showed varying success rates, likely the result of varying sample
sizes and inconsistent LD structure across the genome. Lastly, higher density SNP
arrays provided more defined QTL boundaries than those obtained with medium density
arrays because closer SNPs allow better definition of the local LD structure. The
general trend for GWAS approach seems to focus on increasing analysis performance
through statistics, increased sample size, and increased SNP array density, with little
focus on the phenotype. Thus, exploring the phenotypes used and the conditions they
are generated under could provide important information in the context of GWAS.
21

Candidate Genes Identified by Loci Associated with Mastitis Phenotypes
While numerous genome loci have been associated with mastitis phenotypes
using GWAS, the potential candidate genes surrounding these loci are even more
numerous. Functions of potential candidate genes can be implicated in many aspects
of mastitis progression and are summarized below. Of note, the previous review by
Pighetti and Elliott (2011) covered a range of candidate genes including those for
pathogen recognition, immune cell migration, bacterial elimination, and resolution of
infection.
The innate immune system is composed of non-specific mechanisms that are
initiated within hours or immediately upon antigen recognition, including things like antimicrobial peptides. Several of the loci associated with mastitis phenotypes have
provided candidate genes that fall within the functions of innate immunity. Within a QTL
located on BTA 6, is the GC gene that codes for Gc-globulin. Gc-globulin leads to
cathelicidin antimicrobial peptide synthesis by delivering vitamin D needed for synthesis,
to target monocytes and also helps to enhance macrophage phagocytosis (Hewison
2011; Yamamoto and Homma 1991). Regions on BTA 13 associated with SCS include
genes for β-defensins such as: DEFB117, DEFB119, DEFB122, DEFB122A, DEFB129
and 2 precursor genes (Cormican et al. 2008). Another QTL region on BTA 17 is in
close proximity to SDF2L1 (stromal cell-derived factor 2-like protein 1) gene which plays
a role in processing many β-defensins (Zheng et al. 2012). β-defensins are a family of
anti-microbial peptides that are responsible for initiating the immune response and
preventing microbial colonization of epithelial surfaces which are known to be
expressed in mammary tissue (Ganz 2003; Goldammer et al. 2004; Swanson et al.
2004). The gene for C9 is located near a QTL region identified on BTA 20 and codes
for the precursor for the pore-forming unit of the complement membrane attack
complex. The complement complex aids in the clearance of microorganisms by
introducing pores into microbe membranes and mutations in the C9 gene have been
linked to increases susceptibility to some infections (Horiuchi et al. 1998; Kira et al.
1998; Ricklin et al. 2010; Zoppi et al. 1990). Also nearby to the identified BTA 20 region
is the LIFR gene which produces leukemia inhibitory factor receptor, subunit α. Once
the receptor binds leukemia inhibitory factor its effects include modulation of the
inflammatory response and stimulation of hepatocytes to produce acute-phase proteins
(Baumann and Wong 1989; Linker et al. 2008). Each of these functions aid in the
clearance of invading bacteria and could be implicated in mastitis incidence.
Once bacteria are recognized by the immune system, the recruitment of immune
cells to the site of infection to aid in infection resolution begins. Identified regions on
BTA 1, 13, 17, and 20 are close to genes with immune cell recruitment implications. An
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identified QTL on BTA 1 is located within the gene for CD166 antigen or ALCAM.
CD166 antigen is heavily implicated in leukocyte adhesion, migration and the activation
of T-cells in human cancers and shows ties to mastitis resistance in challenged somatic
cells from sheep (Bonnefont et al. 2011; Cayrol et al. 2008; Hassan et al. 2004;
Zimmerman et al. 2006). The gene for EDN3 (endothelin 3) is located near a QTL
region on BTA 13. EDN3, expressed by several cell types including macrophages, has
vasoconstrictive effects and potentially activates neutrophils needed to phagocytose
microorganisms (Elferink and De Koster 1998; Giaid et al. 1991; Selsted and Ouellette
2005). Also near the QTL on BTA 13 is Phactr 3 (Phosphatase and actin regulator 3)
which interacts with cell cytoskeleton to facilitate cell migration and spreading essential
for mobilizing immune cells (Luster et al. 2005; Sagara et al. 2009). The IL31Rα gene,
which acts in the IL-31 receptor complex, is located near a BTA 20 QTL. Upon binding
cytokine, the IL-31 receptor complex activates JAK-STAT and MAPK pathways which in
turn initiate a several other immune processes (Cornelissen et al. 2012; Zhang et al.
2008). Additionally, the gene for MAPK1, which is a member of the MAPK family and is
essential for leukocyte recruitment following bacteria invasion, is located near a QTL on
BTA 17 (Herlaar and Brown 1999; Kaminska 2005). Deficiencies in the recruitment of
immune cells to the site of infection could allow for increased incidence of mastitis or
chronic infections develop.
In addition to response genes above, other genes related to T-cells, B-cells, and
antibodies are potential candidate genes. A region identified on BTA 6, has its most
significantly associated SNP within the DCK (deoxycytidine kinase) gene. The DCK
gene catalyzes the rate limiting step deoxyribonucleoside salvage and results in low
production of T- and B-cells when knocked out in mice linking its function to
lymphopoiesis (Toy et al. 2010). Also in this region on BTA 6, is the gene for IGJ
(immunoglobulin J polypeptide), which aids assembly of IgM pentamers and IgA dimers.
Both IgM and IgA play critical roles in defending hosts from microorganisms, with IgM
being the first antibody produced after microbial recognition and IgA adhering to
microbes on mucosal surfaces to help prevent adherence to epithelial cells (Lamm
1997; Racine and Winslow 2009). Also on BTA 6, associated with another region, is the
candidate gene DAPP1 or Bam32, which has suspected roles in B-cell receptor
signaling (Pierce 2002). B-cell receptors, upon binding antigen, help designate B-cell
fates like proliferation, differentiation, receptor internalization, and T-cell adhesion and
subsequent activation (Al-Alwan et al. 2010; Han et al. 2003; Niiro et al. 2004).
Additionally, the gene for NPFFR2, a member of the NPFF RFamide neuropeptides, is
located in this region. These neuropeptides decrease macrophage nitric oxide
production producing anti-inflammatory activity in mouse models and can influence Tcell proliferation (Jhamandas and Goncharuk 2014; Lecron et al. 1992; Minault et al.
23

1995; Sun et al. 2013). Lastly, on BTA 19, an identified QTL region is close to the
mTORC1 (mTOR complex 1) gene which influences T-cell functions (Zeng et al. 2013).
Functions above involved in specific antigen responses have the potential to alter
response to mastitis pathogens.
A few candidate genes were identified based on changes in expression level
following challenge with mastitis pathogens or their components. Both the IGLL-1
(lambda-like polypeptide 1 precursor) and the SNAP29 (synaptosomal-associated
protein 29) genes are located near QTL identified on BTA 17 and have demonstrated
up-regulated expression following bacterial challenge in different models (Swanson et
al. 2009; Wesolowski et al. 2012). Additionally, a micro-RNA, mir301b, has
demonstrated down regulation following lipopolysaccharide (LPS) challenge. It is
located near the same QTL region on BTA 17 (Zheng et al. 2012). While it is unclear
the actual function these genes may play in mastitis, their changes in expression level
following challenge suggest they are influenced by pathogenic bacteria presence.
Perhaps such genes could be used in PCR based diagnostic techniques if their
expression changes are consistent across pathogens.
Lastly, some loci on BTA 5, 6, 13, 20, associated with mastitis phenotypes are
also associated with milk phenotypes, particularly with decreased milk yield (Grisart et
al. 2002; Meredith et al. 2012; Sahana et al. 2014; Sahana et al. 2013). The concurrent
association with mastitis and milk yield traits suggests the effects of the detected genes
are pleiotropic and support the widely accepted correlation between SCS and
decreased milk production (Carlén et al. 2004). Within these identified regions for milk
and mastitis traits there are genes that could be implicated in pathways for milk
synthesis. The region located on BTA 5 is within the intron of the MGST1 (microsomal
glutathione S-transferase 1) gene. MGST1 is localized to sites of lipid synthesis within
the cell, thought to protect against oxidative stress, and can catalyze lipid
hydroperoxides making it an excellent candidate for a milk fat QTL (Johansson et al.
2010; Mosialou et al. 1995). Close to the region identified on BTA 6 are several Casein
related proteins. Caseins are the primary protein component of bovine milk, and a QTL
for milk protein exists in this region while not actually mapping to within one of the
casein related genes, thus indicating the potential for multiple causative polymorphisms
(Sahana et al. 2014).
The range of candidate genes discussed above, while far from all-inclusive,
demonstrates QTL associated with mastitis phenotypes are numerous and include a
variety of functions. Trends in identified genes are: antimicrobial peptides, immune cell
recruitment and antigen specific immunity. General functions follow trends observed
from the prior review of candidate genes with some being identified in both (Pighetti and
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Elliott 2011). Despite the wide range of genes identified utilizing older and newer
GWAS and QTL analyses, there has been little translation to on farm selection
practices.
In summary, many regions of the bovine genome have been identified as
associated with mastitis phenotypes using a variety of original and revised GWAS
analyses. Many studies have identified similar and/or overlapping regions of
association. Newer technologies strive to improve the results of GWAS analyses by
reducing the probability of false discoveries and narrowing the regions of association to
causative variants. These identified regions have provided any number of candidate
genes with potential to influence a cow’s response to mastitis. Generalized functions of
candidate genes include bacterial recognition, recruitment of immune cells, and antigen
specific immune responses. However, little conversion of these associated loci is
observed to commonly used selection parameters on farm. Frequently, the easiest and
least expensive way to acquire access to sample sizes adequate for GWAS analyses in
the dairy industry is to rely on public data bases or government records for phenotype
information. This is largely because acquiring the resources and financial support to
house, milk, and collect data on a large population of dairy cows is not feasible for one
researcher or even a team of researchers. As a result, phenotypes utilized in dairy
GWAS are frequently derived from daughter yield deviations (DYD) or estimated
breeding values (EBV). Both EBVs and DYDs are estimates or predictions of a sire’s
progeny based on averages of all the bull’s existing, mature offspring, and do not
represent that individual cow’s performance directly. Thus, there is little ability to
account for the effect of environment or the proportion of genetics received from the
dam, both of which may cause fluctuation in cows’ mastitis phenotype. Furthermore,
Pszczola and Calus (2015) determined that databases used to determine DYD or EBV
need to be updated with a minimum of 600 individuals per generation to remain reliable
in their ability to predict, which can become costly depending on the phenotype in
question. These discrepancies, could account for a portion of the reason why a great
deal of research is being completed in identifying regions, but little evidence of
translation to on farm use of selection for or against discovered loci is observed.
Perhaps developing novel phenotypes from data collected on smaller sample sizes in
response to direct challenge with common mastitis pathogens could narrow the field of
identified associations. Additionally, identified loci would be associated to the pathology
of the challenge organism, leading to better candidate genes increasing the likelihood of
developing novel treatments, preventatives or vaccinations specific to pathogens.
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Abstract
Mastitis is a detrimental disease in the dairy industry that costs upwards of $2
billion annually and decreases milk quality. Often, mastitis results from bacteria
entering the gland through the teat end. A common mastitis causing pathogen is S.
uberis, which is responsible for a high percentage of subclinical and clinical mastitis
cases. Following an intramammary experimental challenge with S. uberis on Holstein
cows (n=40), milk samples were collected and somatic cell counts (SCC) were
determined by the Dairy Herd Improvement Association Laboratory. Traditional GWAS
have utilized test day SCC, SCC over an entire lactation, or sire EPD/DYD SCC to
identify loci of interest for mastitis. Our approach utilizes SCC collected following direct
S. uberis experimental challenge to generate three novel phenotypes: area under the
curve (AUC) of SCC for 0-7 d and 0-28 d post-challenge; and individual cows were
placed in one of three categories (<21 d, 21-28 d, or >28 d) based on when their SCC
returned to below 200,000 cells/ml post-challenge. To identify loci of interest a 50K
SNP chip analysis was performed using the BovineSNP50 v2 DNA BeadChip from
Illumina. Associations were tested using Plink and identified 16 significant (p < 9.34x
10-5) SNPs across the 3 phenotypes. Five of the identified SNPs are located within
previously identified quantitative trait loci (QTLs) for traits with links to our generated
phenotypes. Additionally, six identified SNPs are located within known genes whose
functions can be linked to SCC. The identified loci should be further investigated to
potentially identify causation behind the observed phenotypes. Such investigations
could lead to novel treatment and prevention compounds/protocols for S. uberis mastitis
or genetic selection methods for cows with greater potential to resist S. uberis infection.
Introduction
Mastitis, the inflammation of the mammary gland, decreases milk quality and
farm revenues generated. Data shows mastitis can affect 20-50% of a herd causing an
increase in cow morbidity and mortality (Bradley et al. 2007; Østerås et al. 2006;
Piepers et al. 2007; Wilson et al. 1997). Due to the prevalence and impact of mastitis,
34

increased preventative and control methods are a long standing goal of the dairy
industry. Mastitis frequently results from pathogenic bacteria invading the mammary
gland. Common mastitis causing pathogens include Escherichia coli, Streptococcus
uberis, and Staphylococcus aureus, where each pathogen has its own unique pathology
(Schukken et al. 2011). S. uberis is responsible for a high percentage of both clinical
and subclinical mastitis and is commonly isolated during the dry (non-lactating) period
(Bradley et al. 2007; Petrovski et al. 2011; Riekerink et al. 2008; Verbeke et al. 2014).
Due to S. uberis’s prevalence and its classification as both an environmental and
contagious pathogen, it is often used as a model organism in challenge studies (Zadoks
2007). Once bacteria invade the mammary gland, epithelial cells and resident
macrophages release cytokines which recruit polymorphonuclear neutrophils (PMN)
and other leukocytes to the site of infection (Paape et al. 2003). This cytokine
recruitment results in a large influx of leukocytes into the milk, where leukocytes are
commonly referred to as somatic cells. Somatic cell counts (SCC), represented as
cells/mL, are routinely monitored by the majority of dairy producers and are used as an
indicator for the level of intramammary infection or mastitis. There are some resident
leukocyte populations in the mammary gland and/or milk (i.e.: macrophages) meaning,
even when pathogenic bacteria are not present in the gland, SCC is greater than zero.
Industry standard considers a SCC below 200,000 cells/mL a healthy gland and SCC
above 200,000 cells/mL to indicate either subclinical or clinical mastitis (Dohoo et al.
2011; Schepers et al. 1997; Schukken et al. 2003). Subclinical mastitis is indicated by
an increase in SCC, whereas clinical mastitis is represented by an increase in SCC and
the presence of clinical signs (i.e.: inflammation, altered milk production). Additionally,
SCC are often converted to somatic cell scores (SCS), which are the log transformation
of SCC.
Traditional selection for cows with higher milk production has inadvertently
selected for cows that are also more susceptible to diseases including mastitis (Rupp
and Boichard 2003). Existing mastitis/SCC heritability calculations, ranging from 0.05 to
0.27, are based on test day measurements or measurements over an entire lactation,
which do not account for variation in SCC based on causative pathogen (Haile-Mariam
et al. 2003; Kennedy et al. 1982; Weller et al. 1992). Additionally, the low SCC
heritability means the selection response is proportionally small and gene interaction(s)
and/or environmental factor(s) likely influence SCC heritability. The advent of high
throughput genotyping arrays has allowed researchers to perform genome wide
association studies (GWAS) to identify specific loci or single nucleotide polymorphisms
(SNPs) within the genome that are associated with SCC or related phenotypes instead
of relying solely on traditional bull proofs, which are based on observed phenotype
selection. The results obtained from GWAS are primarily influenced by two factors: the
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coverage of the array (i.e.: number of SNPs genotyped) and the number of individuals
genotyped, amongst other smaller factors (Spencer et al. 2009). The GWAS approach
relies heavily on the SNPs included in the array being in linkage disequilibrium (LD), the
non-random association of alleles at different loci, with the causal variant. The greater
the LD between the SNP and the causal variant, the greater the power to detect the
association (Spencer et al. 2009). Genome arrays are available in a variety of coverage
density, which refers to the number of SNPs genotyped, from low density (7,000 SNPs)
to high density (780,000 SNPs). Genotyping a larger number of SNPs by using a higher
density array can increase the power of GWAS results, however, due to the high degree
of LD present in the Holstein breed, a medium density array (54,000 SNPs) should
provide sufficient detection power (de Roos et al. 2008).
Recent mastitis GWAS have utilized medium density arrays to detect
associations successfully (Cole et al. 2009; Meredith et al. 2012; Pryce et al. 2010).
These studies took advantage of national genetic breeding evaluations (EBV or DYD)
for SCC/SCS kept by departments of agriculture or breed associations to develop
phenotypes for association testing. Both estimated breeding values (EBVs) and
daughter yield deviations (DYDs) are estimates or predictions of a bull’s progeny based
on averages of a sampling of the bull’s offspring, and do not represent an individual
cow’s performance directly nor do they account for variation in SCC based on stage of
lactation or causative pathogen. To circumvent this confounding variation and directly
utilize an individual cow’s performance against a particular pathogen as the phenotype
of interest, we propose utilizing SCC data collected from direct experimental challenge
with S. uberis to develop phenotypes and test associations. We hypothesize utilizing
our novel SCC phenotypes derived from S. uberis experimental challenge will detect
significant associations with SNPs and identify potential target genes directly related to
S. uberis mastitis pathogenesis post-partum. The objective of this study was to perform
a GWAS utilizing 40 Holstein dairy cows that were genotyped using the Illumina
BovineSNP50 v2 BeadChip (54,609 SNPs) to test associations with novel SCC
phenotypes derived SCC collected following direct experimental S. uberis challenge.
Materials and Methods
Animal Selection
Holstein dairy cows (N = 40) that were entering their second or third lactation
were enrolled in a vaccine trial to test the effectiveness of a novel vaccine candidate
against S. uberis, i.e.: Streptococcus uberis adhesion molecule (SUAM) that involved a
direct S. uberis challenge (USDA-NIFA AFRI 2011-67015-30168). Cows were in overall
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good health, pregnant, at the end of their first or second lactation, had quarter SCC
<250,000 cells/mL, and were free of Johne’s, brucellosis, tuberculosis, and bovine
leukemia virus (BLV). Both S. uberis and SUAM baseline titers were assessed and
cows with the lowest titers were enrolled. All cows were housed at the East Tennessee
Education and Research Center (ETREC) Little River Dairy (Walland, TN). Upon arrival
at ETREC, cows were acclimated to the facility for two weeks prior to the initiation of
research protocols. Cows were housed separately from the core herd and cared for in
accordance with ETREC Little River Dairy standard protocols. All animal based work
was approved by and done in accordance with Institutional Care and Use Committee
(IACUC) guidelines.
Challenge
Approximately one week prior to calving and at first milking post-calving,
secretion samples were collected from each quarter to screen for bacterial presence to
select a challenge quarter free of pathogens. A frozen stock of Streptococcus uberis
(UT888) was thawed in a 37°C water bath and an aliquot used to inoculate a blood agar
plate. After 23-24 h of growth on the agar, 3 representative colonies were used to
inoculate Todd Hewitt Broth for an additional 7 h of growth. The 1 mL aliquot of the
resulting liquid culture was serially diluted in PBS to approximately 2,000 CFU for
infusion. A total of 5 mL of the diluted culture was used for challenge, resulting in a total
of 10,000 CFU delivered. Challenge was performed within 3 days post-calving with 5
mL of the diluted S. uberis culture immediately following milking. Prior to intramammary
infusion, teat ends were cleaned thoroughly with sterile alcohol pads and the inoculum
was infused using sterile disposable syringes with teat cannulas. The challenge
inoculum was massaged upward into the teat and gland cisterns and plated (100μL) to
determine the actual CFU/mL of S. uberis delivered which averaged 2122 ± 371
CFU/mL and ranged from 1185 to 3202 CFU/mL.
Sampling and Phenotype Description
Milk samples were collected from the challenge quarter in Capitol Vials with B-14
milk preservative pills (Neta Scientific, Inc., Hainesport, NJ) at the following time points:
immediately before challenge (0 d) and then 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6,
6.5, 7, 11, 14, 18, 21, 25, and 28 d post-challenge. Collected samples were used to
determine somatic cell counts (SCC), represented as cells/mL, by the Tennessee Dairy
Herd Information Association (DHIA) lab (Knoxville, TN). From the SCC data, three
phenotypes were developed. Industry standard considers a SCC below 200,000
cells/mL healthy, individual cows were placed in one of three categories (<21 d, 21-28
d, or >28 d) based on when their SCC returned to below 200,000 cells/mL post37

challenge, which will be referred to as SCC cure. Additionally, area under the curve
(AUC) for SCC cells/mL for 0-7 days and 0-28 days post-challenge were calculated
from linear representations of SCC over time for each cow using SAS (Cary, NC), and
will be referred to as 7d AUC and 28d AUC respectively. AUCs were calculated in
order to have a single value for each cow to test for genetic associations, since looking
at effects over time is not possible with a GWAS approach. Select cows were sacrificed
throughout the post-challenge sampling as part of the SUAM vaccine trial which
resulted in incomplete data sets to generate phenotypes for some cows. As a result,
the number of cows per phenotype differed as follows: SCC cure had N=34, 7d AUC
had N=36, and 28d AUC had N=35.
SNP Chip Analysis
Blood samples were collected from each cow via jugular puncture and DNA was
isolated using UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).
Resulting DNA was used to perform a 50K SNP chip analysis using the BovineSNP50
DNA Analysis BeadChip (Illumina, San Diego, CA) (Gunderson et al. 2005; Steemers et
al. 2006). The SNP chip has 54,609 SNPs that span all 29 autosomes of the bovine
genome with an average SNP spacing of 49.4kb and a median spacing of 36.9kb.
Associations were tested between developed phenotypes and SNPs using Plink
(Purcell et al. 2007). Effects of sex were excluded from the analysis because all
individuals were female and SNPs did not represent sex chromosomes. The p-value
cutoffs of p < 1.95x10-5 for highly significant SNPs and p = 1.95x10-5 to 9.34x10-5 for
suggestively significant SNPs were set based on guidelines for reducing false positives
and increasing reproducibility (Manly 2005). For identified SNPs to be reported, the
minor allele had to be represented by more than one cow, unless the SNP aligned with
prior evidence for mastitis or mastitis related traits. A complete index of identified
SNPs, including those removed based on the minor allele criteria, is included as an
appendix (Table A-1). To allow depiction of the numerous SNPs, their genome
locations, and their variable association p-values, generated Plink results were
visualized using Manhattan plots created with Integrated Genome Viewer (IGV)
(Robinson et al. 2011). All reported gene and SNP locations were reported based on
the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build.
Results
A total of 16 SNPs associated with unique SCC phenotypes generated from S.
uberis experimental challenge data were identified. The identified SNPs spanned 11
chromosomes, with 3 SNPs on BTA 9 and 20, 2 SNPs on BTA 3, and the remaining 8
SNPs being unique to individual chromosomes (Table 1). The first phenotype, SCC
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Table 1: Identified loci associated with developed novel SCC phenotypes.
Trait

rs

Locus
1
(chr: bp )

SNP type

Allele freq

2

Nearest
gene(s)

Prior evidence

P-value

Loci with prior evidence
7d AUC

rs109961240

20: 63,407,185

5’ upstream

A: 0.32 G: 0.68

TAS2R1

28d AUC

rs41655875

5: 26,621,180

intron variant

C: 0.07 T: 0.93

ATF7

28d AUC

rs109513885

3: 34,263,481

intron variant

C: 0.41 T: 0.59

CELSR2

SCC cure

rs42488893

8: 19,967,642

5’ upstream

C: 0.62 T: 0.38

U6 (snRNA)

SCC cure

rs29015249

18: 24,862,274

intergenic

C: 0.36 T: 0.64

BREH1,
NUP93

SCS QTL
(Meredith et al.,
2013)
MY QTLs
(Bennewitz et
al., 2004, Awad
et al., 2010)
MY QTLs
(Viitala et al.,
2003, Ashwell
et al., 2004)
SCC QTL, CM
QTL (Klungland
et al., 2001)
PL QTL, SCS
QTL,
MY QTL
(Olsen et al.,
2002, Muncie
et al., 2006)

4.14x10

-6

2.80x10

-5

5.67x10

-5

6.89x10

-5

8.88x10

-5

Newly identified loci
--

8.54x10

-7

--

5.57x10

-6

A: 0.76 G: 0.24

TIAM2
CHMP2B,
VGLL3
LOC100336821

--

8.00x10

-6

intron variant

C: 0.45 T: 0.55

CPE

--

1.82x10

-5

20: 59,627,852

5’ upstream

C: 0.43 T: 0.57

DNAH5

--

2.82x10

-5

rs110556992

7: 65,047,126

intron variant

C: 0.56 T: 0.44

GLRA1

--

4.86x10

-5

rs41594141

9: 73,368,179

intron variant

A: 0.60 G: 0.40

SGK1

--

5.43x10

-5

SCC cure

rs109484182

9: 93,183,596

intron variant

A: 0.51 G: 0.49

28d AUC

rs43224998

1: 34,903,570

intergenic

A: 0.72 G: 0.28

SCC cure

rs110216702

9: 100,163,987

intron variant

SCC cure

rs29019936

17: 562,366

7d AUC

rs41951389

28d AUC
SCC cure
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Table 1: Continued
SNP type

Allele freq

rs41612729

Locus
1
(chr: bp )
28: 5,052,476

5’ upstream

A: 0.56 G: 0.44

rs41565622

13: 24,688,809

intron variant

A: 0.53 G: 0.47

Trait

rs

7d AUC
SCC cure

2

Nearest
gene(s)
DISC1

LOC530173
RGS5,
28d AUC
rs43499732
3: 6,480,313
intergenic
G: 0.20 T: 0.80
CCDC190
TRIO, TRNAC7d AUC
rs109243453
20: 58,928,800
intergenic
A: 0.40 G: 0.60
ACA
1
Reported positions are based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build.
2
Allele frequencies are representative of the current study population.
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Prior evidence

P-value

--

6.48x10

-5

--

8.32x10

-5

--

8.48x10

-5

--

8.59x10

-5

cure, placed cows in one of 3 categories based on when during the post-challenge
sampling each cow’s SCC returned to below 200,000 cells/mL (Figure 1). The majority
of cows (44%) were in the >28 days category, indicating their SCC had not returned to
below 200,000 cells/mL before the sampling period ended at 28 days post-challenge.
The next largest category was <21 days, which included 32% of cows that reached
200,000 cells/mL before 21 days post-challenge. The last category of 21 – 28 days was
the smallest category and represented only 24% of cows. Association analyses
identified 3 highly significant (p < 1.95x10-5) and 4 suggestively significant (p = 1.95x10-5
to 9.34x10-5) SNPs associated with SCC cure (Figure 2). One suggestively significant
SNP is located on each BTA 8 (rs42488893), 13 (rs41565622), and 18 (rs29015249) in
regions not associated with any known functions. A significant SNP (rs29019936) is
located on BTA 17 within the CPE (carboxypeptidase E) gene and the remaining three
SNPs are part of a cluster of SNPs located on BTA 9, with SNPs in both the TIAM2 (tcell lymphoma invasion and metastasis 2) (rs109484182), SGK1 (serum/glucocorticoid
regulated kinase 1) (rs41594141), and LOC100336821 (rs41565622) genes.
The second and third phenotypes were a quantitative representation of SCC
AUC over time, either for the first 7 days post-challenge (7d AUC) or for the entire 28
day sampling period (28d AUC). For 7d AUC, areas ranged from 1.7x10 6 (cells/mL)*d
to 91.3x106 (cells/mL)*d, and had a median of 30.6x106 (cells/mL)*d (Figure 3).
Association analyses identified 1 highly significant (p < 1.95x10 -5) and 3 suggestively
significant (p = 1.95x10-5 to 9.34x10-5) SNPs associated with 7d AUC (Figure 4). One
SNP (rs41612729) is located on BTA 28 and the remaining three SNPs are part of a
cluster of SNPs on BTA 20 (rs109961240, rs41951389, and rs109243453). None of the
SNPs identified with 7d AUC are located in regions with known functions. For 28d AUC,
areas ranged from 2.5x106 (cells/mL)*d to 246.1x106 (cells/mL)*d, with a median of
69.4x106 (cells/mL)*d (Figure 3). Association analyses identified 1 highly significant (p
< 1.95x10-5) and 4 suggestively significant (p = 1.95x10-5 to 9.34x10-5) SNPs associated
with 28 day AUC (Figure 5). One SNP was identified on each BTA 1, 5, and 7, where
the SNP on BTA 5 (rs41655875) is in the ATF7 (activating transcription factor 7) gene
and the SNP on BTA 7 (rs110556992) is in the GLRA1 (glycine receptor, alpha 1) gene.
The remaining 2 SNPs were both on BTA 3, with one located in the CELSR2 (cadherin,
EGF LAG seven-pass G-type receptor 2) gene (rs109513885).
Discussion
This study successfully identified associations between SNPs in the bovine
genome and novel SCC phenotypes developed from SCC following direct S. uberis
experimental challenge. To our knowledge, this study is the first to utilize data
generated from an experimental challenge to develop GWAS mastitis phenotypes.
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Number of Cows

16
14
12
10
8
6
4
2
0

N=15
N=11
N=8

<21 d

21 - 28 d

>28 d

Days Post-challenge SCC Returned Below 200,000
cells/mL
Figure 1: Number of cows per SCC cure phenotype category. Ranges of days
represent the time range individual cow’s SCC returned to below 200,000 cells/mL,
which is industry standard for healthy.
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Figure 2: Manhattan plot of GWAS for SCC cure phenotype using BovineSNP50 v2
BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34). The x-axis shows
chromosome and SNP order within a chromosome. The y-axis show the –log(p-value)
for each SNP. P-value thresholds are indicated by dashed lines: top black line p =
1.95x10-5; bottom gray line p = 9.34x10-5.
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AUC in Millions

1000
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246
91
69.4

30.6

Maximum
Median
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1
1.7

2.5

SCC 7 d AUC

SCC 28 d AUC

0.1
Phenotype
Figure 3: Minimum, median, and maximum SCC AUC values for both 7 and 28 d
phenotypes displayed in millions of (cells/mL)*d.
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Figure 4: Manhattan plot of GWAS for SCC 7 day AUC phenotype using BovineSNP50
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36). The x-axis shows
chromosome and SNP order within a chromosome. The y-axis show the –log(p-value)
for each SNP. P-value thresholds are indicated by dashed lines: top black line p =
1.95x10-5; bottom gray line p = 9.34x10-5.
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Figure 5: Manhattan plot of GWAS for SCC 28 day AUC phenotype using
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35). The x-axis
shows chromosome and SNP order within a chromosome. The y-axis show the –log(pvalue) for each SNP. P-value thresholds are indicated by dashed lines: top black line p
= 1.95x10-5; bottom gray line p = 9.34x10-5.
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Additionally, this study is unique because of its power, with N=34-36 Holstein cows
compared to hundreds of individuals in other GWAS studies focused on mastitis
(Meredith et al. 2013; Sahana et al. 2014; Tal-Stein et al. 2010). However, 5 of the
identified SNPs in this study (rs109961240, rs41655875, rs109513885, rs42488893,
and rs29015249) are located in genomic regions with prior evidence associated with
mastitis or related phenotypes (Table 1). Of these, the SCC cure phenotype was
associated with SNP rs42488893 which was also within a clinical mastitis (CM) QTL
(Klungland et al. 2001). This CM QTL was a binary trait where cows either had or did
not have CM from 15 d pre-calving to 120 d post-calving. Our SCC cure phenotype
focused on the first 28 d post-calving, during which we observed 62.5% of cows develop
clinical mastitis, indicated by inflammation, altered milk production, and an elevated
(>200,000 c/mL) SCC (data not shown). The highly inflammatory response observed
with clinical mastitis suggests a strongly stimulated immune response, which could led
to a more efficient clearance of invading bacteria and result in a shorter period of time
with SCC >200,000 c/mL, correlating to a lower SCC cure phenotype. Three SNPs
significantly associated with the phenotypes 7d AUC (rs109961240) and SCC cure
(rs42488893, rs29015249) were located within QTLs associated with SCC and SCS
(Klungland et al. 2001; Meredith et al. 2013; Muncie et al. 2006). These QTLs used
SCC lactation means or SCC averaged across a sire’s daughters as phenotypes
meaning loci identified are likely associated with cows with higher propensity for
infections or cows with longer recovery times post-infection. The 7d AUC phenotype
accumulated SCC for the first 7 days post-challenge, where cows with higher 7d AUC
would have higher propensity for infection and those with lower 7d AUC would have
lower propensity, which links our 7d AUC phenotype directly to the previously identified
QTLs. The SCC cure phenotype put cows in categories based on when their SCC
returned to below 200,000 c/mL, indicating a healthy gland, which would correlate to
cows with length of time it takes for cows to recover post-infection linking SCC cure
directly to the previously identified SCC/SCS QTLs. Of interest, SNPs associated with
28d AUC (rs41655875, rs109513885) and SCC cure (rs29015249) phenotypes were
located in regions previously identified as having QTLs for productive life (PL) and/or
milk yield (MY) (Ashwell et al. 2004; Awad et al. 2010; Bennewitz et al. 2004; Muncie et
al. 2006; Olsen et al. 2002; Viitala et al. 2003). Productive life refers to the length of
time a cow remains in the herd producing milk, which can be affected my many factors
including health, fertility, and milk yield (Roxström and Strandberg 2002). A longer SCC
cure (i.e.: >28d) and/or stronger inflammatory responses for 28d (AUC) indicates cows
are not as effective at resolving infection. This would increase their risk of being culled
from the herd because of mastitis directly or other negative impacts associated with
mastitis such as reduced fertility and milk yield. For decades, an association between
mastitis incidence and reduced milk production has been recognized (Meredith et al.
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2012; Shaw and Beam 1935; Wilson et al. 1997) since fighting infections sequesters
energy that would otherwise be partitioned to milk production. Since SCC is used as an
indicator of mastitis, is the foundation for both our SCC cure and 28d AUC phenotypes,
and is associated with decreased milk production, the identification of SNPs in regions
with MY QTLs is logical. The identification of SNPs within known QTL regions with prior
evidence helps establish the validity of using these novel SCC based phenotypes in
response to direct, experimental S. uberis challenge for GWAS. Furthermore, while the
associations identified in this study are associated with our novel S. uberis SCC
phenotypes, since some of the identified SNPs are located in regions with prior
evidence linked to varying mastitis and/or MY phenotypes, it is possible these regions
could be associated with other causative pathogens besides S. uberis.
While the identified SNPs themselves may not be causal but rather in linkage
disequilibrium is the causal variant, they do provide several interesting candidate genes
based on the genes they are located within. Of the previously identified loci, the two
identified using 28d AUC are also located within genes with known functions. First,
rs41655875 is located within the ATF7 (activating transcription factor 7) gene. ATF7
binds the cAMP response element of many cellular promoters including many immune
genes and helps control the epigenetic regulation of the same genes resulting in the
speculation that ATF7 is involved in the controlling the ‘memory’ of the innate immune
system through these epigenetic changes that persist for long periods of time (Yoshida
et al. 2015). Control of the innate immune system through gene regulation would allow
for faster responses to infection states and allow for rapid clearance of invading bacteria
and be associated with overall lower 28d AUC. The other SNP, rs109513885, is
located within the CELSR2 (cadherin EGF LAG seven-pass G-type receptor 2) gene
that is primarily involved in central nervous system dendrite morphogenesis (Shima et
al. 2007). The functions of CELSR2 are linked to calcium signaling, cell adhesion, and
cell survival, which are functions shared with many g-protein receptors (Beall et al.
2005; Shima et al. 2007) frequently involved in migration of immune cells to the site of
infection (Raman et al. 2010; Rambeaud et al. 2006; Rambeaud and Pighetti 2007;
Richardson et al. 2003), thus impacts in CELSR2 might impact observed SCC and be
linked to a higher or lower 28d AUC.
In addition to the SNPs identified in regions with prior evidence, this study
identified 12 novel SNPs. The SCC cure phenotype identified 5 novel SNPs, of these, 3
are within genes with known functions. First, rs109484182, located on BTA 9 at
93.2Mb, is within the TIAM2 (t-cell invasion and metastasis-2) gene, which encodes a
guanine nucleotide exchange factor that plays a role in the function of small GTPases.
Roles of TIAM2 based on human research have included increasing cell invasions in
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cancer development, cellular migration, adhesion, and apoptosis (Chen et al. 2012;
Rooney et al. 2010). While the majority of existing research has focused on TIAM2’s
role in cancer development and metastasis, it has documented roles in general immune
functions like migration and apoptosis that could affect a cow’s SCC influx in response
to invading pathogenic bacteria and thus its SCC cure phenotype. Another SNP,
rs41594141, also located on BTA 9, but at 73.4Mb, is within the SGK1
(serum/glucocorticoid regulated kinase 1) gene, which is a serine/threonine kinase that
is expressed in virtually all tissues where it regulates ion channels (Lang et al. 2009;
Lang and Shumilina 2013). SGK1 also helps regulate the expression of NFκB, which is
a transcription factor for many genes involved in effector functions of innate immune
system (Baeuerle and Henkel 1994; Lang et al. 2010). NFκB regulated effector
functions include the up regulation of the pro-inflammatory cytokine IL-8 and the
adhesion molecules ICAM-1 and VCAM-1, which are vital for the recruitment of
neutrophils to the site of infection (Collins et al. 1995; Matsusaka et al. 1993).
Alterations in the ability to recruit neutrophils to the mammary gland during mastitis
would likely permit the infection to persist and cause a prolonged period of mildly
elevated SCC that is not sufficient enough to clear the infection and correlating to a high
SCC cure phenotype observed. The third SNP located within a gene identified with the
SCC cure phenotype, rs29019936, is located on BTA 17 at 0.6Mb, and is within the
CPE (carboxypeptidase E) gene that primarily functions within the endocrine and
nervous systems for the biosynthesis of neuropeptides and peptide hormones (Fricker
1988). Neuropeptides and peptide hormones have diverse roles in the regulation of the
immune system including cytokine secretion, adhesion molecule expression, and
feedback regulation as reviewed by Sternberg (2006). Additionally, CPE directly has
been demonstrated to play a role in growth and migration of cancer cells in humans
(Lee et al. 2011). The effects of these roles combined could dictate the ability of
immune cells to migrate to the mammary gland resulting in overall lower SCC observed
which would correlate to lower SCC cure phenotypes.
The 7d AUC phenotype identified 3 novel SNPs. While none of these SNPs
were directly located in genes, there were a cluster of SNPs identified on BTA 20
including SNPs at positions 58.9Mb (rs109243453), 59.6Mb (rs41951389), and 63.4Mb
(rs109961240, previously identified). Several other GWAS have identified associations
with loci on BTA20 and SCC based phenotypes (Cole et al. 2011; Meredith et al. 2013;
Meredith et al. 2012; Sahana et al. 2014; Sodeland et al. 2011; Tal-Stein et al. 2010).
Within this BTA 20 cluster region there are 11 known genes, 4 tRNAs, 1 miRNA, and 7
ncRNAs, providing a number of possible candidate genes and functional RNAs. One
gene of interest is death-associated protein (DAP)-1 which is a positive mediator of
interferon (IFN)-γ induced programmed cell death (Deiss et al. 1995). Higher rates of
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programmed cell death could lead to lower SCC and would correlate to lower 7d AUC
phenotypes observed. Lastly, the 28d AUC phenotype identified the remaining 3 novel
SNPs, where one SNP is located within a gene with known function. The SNP on BTA
7 at 65Mb is located within the GLRA1 (glycine receptor alpha 1) gene. GLRA1 is a
subunit of an ion-gated, chlorine channel glycine receptor. Glycine and its receptor
primarily function within the central nervous system to mediate synapse impulses (Van
den Eynden et al. 2009). Glycine receptors also influence calcium ion fluxes in
neutrophils and monocytes leading to reduced pro-inflammatory cytokine production,
increased anti-inflammatory production, and reduced superoxide production resulting in
overall less stimulation of the immune response to invading pathogens (Spittler et al.
1999; Wheeler et al. 2000). Less stimulation of the immune response would result in
fewer immune cells recruited to the site of infection and lead to overall lower observed
SCC and lower 28d AUC phenotypes.
In summary, our study identified SNPs associated with novel SCC based
phenotypes derived from SCC collected in response to direct, experimental S. uberis
challenge. While our study was limited by a low number of individual cows being
genotyped, many of the identified SNPs (31%) are within genomic regions previously
reported in considerably larger studies as associated with mastitis related traits,
providing validity to the effectiveness of our novel phenotypes for identifying regions of
interest. The identified SNPs provide several loci to investigate as potential target
genes that could be linked directly to S. uberis pathogenesis. Furthermore,
investigations of these identified loci or those identified in future analyses using
challenge data could lead to novel treatment or preventative strategies for S. uberis
mastitis and potentially identify genetic selection markers for cows with greater
resistance to S. uberis mastitis.
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Abstract
Mastitis is a detrimental disease in the dairy industry that costs upwards of $2
billion annually and decreases milk quality. Often, mastitis results from bacteria
entering the gland through the teat end. A common mastitis causing pathogen is S.
uberis, which is responsible for a high percentage of subclinical and clinical mastitis
cases. Following an intramammary experimental challenge with S. uberis on Holstein
cows (n=40), mammary and milk scores were observed to evaluate the level of
inflammation present and aseptic milk samples were collected to determine CFU of S.
uberis present in milk. Traditional GWAS have utilized somatic cell count (SCC) based
phenotypes or clinical mastitis (CM) observations to identify loci of interest for mastitis.
We proposed using novel phenotypes developed from data collected following direct S.
uberis experimental challenge to generate 6 phenotypes. Four phenotypes were
generated using S. uberis CFU: S. uberis 1st clearance which enumerated the days until
CFU reached zero, S. uberis cycles which enumerated the number of times CFU
reached zero within the 28d sampling period, area under the curve (AUC) of S. uberis
CFU for 0-7 d and 0-28 d post-challenge. The last two phenotypes were developed
using mammary and milk scores: severity score summed all scores for the highly
inflammatory 0-7 d post-challenge and chronic score summed all scores for the entire 028 d sampling period post-challenge. To identify loci of interest a 50K SNP chip
analysis was performed using the BovineSNP50 v2 DNA BeadChip from Illumina.
Associations were tested using Plink and identified 29 significant (p < 9.34x 10 -5) SNPs
across the 6 phenotypes. Nine of the identified SNPs are located within previously
identified quantitative trait loci (QTLs) for traits with links to our generated phenotypes.
Additionally, 14 identified SNPs are located within known genes, with most having
functions related to the immune response or gene/protein regulation. The identified loci
should be further investigated to potentially identify causation behind the observed
phenotypes. Such investigations could lead to novel treatment and prevention
compounds/protocols for S. uberis mastitis or genetic selection methods for cows with
greater potential to resist S. uberis infection.
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Introduction
Mastitis affects 20-50% of cows within any given herd resulting in dramatic
decreases in milk quality and farm revenues (Akers and Nickerson 2011; Barbano et al.
1991; Bradley et al. 2007; Klei et al. 1998; Ma et al. 2000; NMC 2005; Østerås et al.
2006; Piepers et al. 2007; Wilson et al. 1997). Because of the impact and high
incidence of mastitis, improved control and prevention is a constant goal of the dairy
industry. Mastitis frequently results from pathogenic bacteria invading the mammary
gland. Common mastitis causing pathogens include Escherichia coli, Streptococcus
uberis, and Staphylococcus aureus, where each pathogen has its own unique pathology
(Schukken et al. 2011). S. uberis is responsible for a high percentage of both clinical
and subclinical mastitis and is commonly isolated during the dry (non-lactating) period
(Bradley et al. 2007; Petrovski et al. 2011; Riekerink et al. 2008; Verbeke et al. 2014).
S. uberis is especially problematic because, while it typically originates as an
environmental pathogen, it can spread throughout the herd in a contagious manner
once introduced (Zadoks 2007). Intramammary infections are characterized by
increases in somatic cell counts (SCC), which enumerate the number of immune cells
recruited to the infection site to combat invading bacteria. Some resident immune cells
(i.e.: macrophages) reside in the mammary gland to provide protection at all time, thus,
industry standard considers a SCC below 200,000 cells/mL a healthy gland and SCC
above 200,000 cells/mL to indicate either subclinical or clinical mastitis (Dohoo et al.
2011; Schepers et al. 1997; Schukken et al. 2003). Subclinical S. uberis infections are
indicated by an increase in SCC, whereas clinical S. uberis infections are represented
by an increase in SCC and the presence of clinical signs (i.e.: inflammation, altered milk
production) (Rambeaud et al. 2003). Additionally, S. uberis has some unique pathology
characteristics that can make clearing the infection from the mammary gland more
problematic. Once S. uberis enters the mammary gland, it binds lactoferrin, which is a
common milk protein (Fang and Oliver 1999). Lactoferrin can then act as a bridging
molecule and allow binding of S. uberis to the mammary epithelial cells (Fang et al.
2000). After binding, S. uberis then invades the host cells via caveolae dependent
endocytosis (Almeida and Oliver 2006; Matthews et al. 1994). Once internalized, S.
uberis can exploit host cell transduction and persist in the cytoplasm for hours (Almeida
et al. 2000; Tamilselvam et al. 2006) effectively evading the host immune system.
Since S. uberis mastitis is a common problem dairy producers combat and S. uberis
has mechanisms to evade the immune response, identifying specific host genes
involved in S. uberis pathogenesis could prove beneficial for the control and prevention
of S. uberis mastitis on dairy farms.
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Many studies attempting to identify genes important for mastitis have been
conducted (Cole et al. 2009; Meredith et al. 2013; Meredith et al. 2012; Pryce et al.
2010). These genome wide association studies (GWAS) have utilized SCC based
phenotypes or observations of clinical mastitis to test for associations. Our prior study,
(Siebert et al., 2017, unpublished) was the first to utilize SCC collected in response to
direct experimental intramammary challenge to identify associations with genomic
regions. For the present study, we propose utilizing other subsets of data (i.e.: CFU of
S. uberis in milk, mammary score, milk scores) collected in response to direct
experimental intramammary S. uberis challenge to develop novel phenotypes and test
associations with the bovine genome. We hypothesize utilizing our novel phenotypes
derived from experimental challenge will increase specificity of associations and identify
potential target genes directly related to S. uberis mastitis pathogenesis. The objective
of this study was to perform a GWAS utilizing 40 Holstein dairy cows that were
genotyped using the Illumina BovineSNP50 v2 BeadChip (54,609 SNPs) to test
associations with novel phenotypes derived data collected following direct experimental
S. uberis challenge.
Materials and Methods
Animal Selection
Holstein dairy cows (N = 40) that were entering their second or third lactation
were enrolled in a trial to test the effectiveness of a novel vaccine candidate against S.
uberis, i.e.: Streptococcus uberis adhesion molecule (SUAM) that involved a direct S.
uberis challenge (USDA-NIFA AFRI 2011-67015-30168). Cows were in overall good
health, pregnant, at the end of their first or second lactation, had quarter SCC <250,000
cells/mL, and were free of Johne’s, brucellosis, tuberculosis, and bovine leukemia virus
(BLV). Both S. uberis and SUAM baseline titers were assessed and cows with the
lowest titers were enrolled. All cows were housed at the East Tennessee Education
and Research Center (ETREC) Little River Dairy (Walland, TN). Upon arrival at
ETREC, cows were acclimated to the facility for two weeks prior to the initiation of
research protocols. Cows were housed separately from the core herd and cared for in
accordance with ETREC Little River Dairy standard protocols. All animal based work
was approved by and done in accordance with Institutional Care and Use Committee
(IACUC) guidelines.
Challenge
Approximately one week prior to calving and at first milking post-calving,
secretion samples were collected from each quarter to screen for bacterial presence to
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select a challenge quarter free of pathogens. A frozen stock of Streptococcus uberis
(UT888) was thawed in a 37°C water bath and an aliquot used to inoculate a blood agar
plate. After 23-24 h of growth on the agar, 3 representative colonies were used to
inoculate Todd Hewitt Broth for an additional 7 h of growth. The 1 mL aliquot of the
resulting liquid culture was serially diluted in PBS to approximately 2,000 CFU for
infusion. A total of 5 mL of the diluted culture was used for challenge, resulting in a total
of 10,000 CFU delivered. Challenge was performed within 3 days post-calving
immediately following milking. Prior to intramammary infusion, teat ends were cleaned
thoroughly with sterile alcohol pads and the inoculum was infused using sterile
disposable syringes with teat cannulas. The challenge inoculum was massaged upward
into the teat and gland cisterns and plated (100μL) to determine the actual CFU/mL of
S. uberis delivered which averaged 2122 ± 371 CFU/mL and ranged from 1185 to 3202
CFU/mL within the 5mL inoculation volume.
Sampling and Phenotype Description
Cows were closely monitored post-challenge for the development of mastitis with
specific collections and observations taken at the following time points: immediately
before challenge (0 d) then 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 11, 14, 18,
21, 25, and 28 d post-challenge. At each time point, a variety of measures were taken
and used to develop novel phenotypes to test for associations with genomic regions.
Milk samples collected aseptically were used to determine the amount of S.
uberis present, in CFU/mL, via culturing on blood agar plates as outlined in the NMC lab
handbook (NMC 1999) and carried out by the Tennessee Quality Milk Lab (Knoxville,
TN). Determined CFU/mL of S. uberis was used to develop four separate novel
phenotypes. All cows became infected from challenge, based on S. uberis isolation
from challenged quarter, thus, all cows had initially high S. uberis CFU/mL postchallenge. The number of days until S. uberis CFU/mL reached zero the first time postchallenge was used to establish the days until S. uberis 1st clearance phenotype.
Some cows showed S. uberis CFU/mL increases following the initial clearance, the
number of times this occurred in the 28 d sampling period was used to identify the
number of S. uberis shedding cycles, which defined the second novel phenotype.
The remaining two S. uberis phenotypes were developed from calculating the area
under the curve (AUC) for S. uberis CFU/mL for 0-7 days (7d AUC) and 0-28 days
(28d AUC) post-challenge from linear representations of CFU/mL over time for each
cow using SAS (Cary, NC). AUCs were calculated in order to have a single value for
each cow to test for genetic associations, since looking at effects over time is not
possible with a GWAS approach.
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Mammary and milk scores on the challenge quarter were evaluated on a 0 to 3
scale by ETREC Little River Staff to make 2 additional novel phenotypes. Mammary
scores were defined as follows: 0 = normal, 1 = slight swelling, 2 = moderate swelling, 3
= edema. Milk scores were defined as follows: 0 = normal, 1 = small flakes or clots, 2 =
large clots, 3 = stringy, off color, watery, or bloody. To focus on cows with a quick and
severe inflammatory response to challenge, mammary and milk scores for the first 7 d
post-challenge were summed to create the severity score phenotype. Contrastingly, to
concentrate on cows with a more slow and steady, chronic response to challenge,
mammary and milk scores were summed for the entire 28 d sampling period to create
the chronic score phenotype.
Of note, select cows were sacrificed throughout the post-challenge sampling as
part of the SUAM vaccine trial which resulted in incomplete data sets to generate
phenotypes for some cows. As a result, the number of cows per phenotype differed as
follows: S. uberis 1st clearance had N=34, S. uberis shedding cycles had N=34, 7d AUC
had N=36, 28d AUC had N=35, severity score had N=36, and chronic score had N=34.
Association Analysis
Blood samples were collected from each cow via jugular puncture and DNA was
isolated using UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).
Resulting DNA was used to perform a 50K SNP chip analysis using the BovineSNP50
DNA Analysis BeadChip (Illumina, San Diego, CA) (Gunderson et al. 2005; Steemers et
al. 2006). The SNP chip has 54,609 SNPs that span all 29 autosomes of the bovine
genome with an average SNP spacing of 49.4kb and a median spacing of 36.9kb.
Associations were tested between developed phenotypes and SNPs using Plink
(Purcell et al. 2007). Effects of sex were excluded from the analysis because all
individuals were female and SNPs did not represent sex chromosomes. The p-value
cutoffs of p < 1.95x10-5 for highly significant SNPs and p = 1.95x10-5 to 9.34x10-5 for
suggestively significant SNPs were set based on guidelines for reducing false positives
and increasing reproducibility (Manly 2005). For identified SNPs to be reported, the
minor allele had to be represented by more than one cow, unless the SNP aligned with
prior evidence for mastitis or mastitis related traits. A complete index of identified
SNPs, including those removed based on the minor allele criteria, is included as an
appendix (Table A-1). To allow depiction of the numerous SNPs, their genome
locations, and their variable association p-values, generated Plink results were
visualized using Manhattan plots created with Integrated Genome Viewer (IGV)
(Robinson et al. 2011). All reported gene and SNP locations were reported based on
the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build.
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Results
A total of 29 SNPs associated with unique novel phenotypes generated from S.
uberis experimental challenge data were identified (Table 2). The identified SNPs span
18 chromosomes, with 2 SNPs each on BTAs 1, 3, 13, 14, 17, 18, 21, 22, and 28. The
first S. uberis CFU based phenotype, S. uberis 1st clearance, enumerated the days until
S. uberis CFU reached zero post-challenge. Days until S. uberis 1st clearance ranged
from 4 to 47 days, and had a median of 23.5 days (Figure 6). Association analyses
identified 3 suggestively significant (p < 9.34x10-5) SNPs associated with S. uberis 1st
clearance time (Figure 7). One significant SNP each was identified on BTA 2
(rs41645172), 11 (rs41610542), and 28 (rs41653441), with the SNP on BTA 28 being
located within the PSAP (prosaposin) gene.
The second S. uberis CFU based phenotype, S. uberis shedding cycles, counted
the number of times S. uberis CFU reached zero within the 28 day post-challenge
sampling period. The number of S. uberis cycles ranged from 1 to 4, with the majority
of cows (47%) being represented by 2 cycles (Figure 8). Three suggestively significant
SNPs (p < 9.34x10-5) were identified as associated with the S. uberis shedding cycles
phenotype (Figure 9). One significant SNP each was identified on BTA 4 (rs41576873),
15 (rs109427689), and 17 (rs41570578). The SNP identified on BTA 4 is located within
the SND1 (staphylococcal nuclease and tudor domain containing 1) gene and the SNP
on BTA 17 is located in the HECTD4 (HECT domain E3 ubiquitin protein ligase 4) gene.
The last two S. uberis CFU based phenotypes were a quantitative representation
of CFU AUC over time, either for the first 7 days post-challenge (7d AUC) or the entire
28 day sampling period (28d AUC). Areas under the curve for 7 days post-challenge
ranged from 24.5 CFU*d to 1.27x108 CFU*d, with a median of 3.17x107 CFU*d (Figure
10). Association analyses identified 9 highly significant (p < 1.95x10 -5) SNPs and 6
suggestively significant (p = 1.95x10-5 to 9.34x10-5) SNPs associated with 7d AUC
(Figure 11). The 7d AUC associated SNPs were located on BTAs 1 (rs110974478), 3
(rs43709346 and rs109880729), 5 (rs43423752), 9 (rs41665257), 12 (rs110866336), 13
(rs110804434), 17 (rs41831243), 18 (rs109290019 and rs109070561), 21
(rs111021268 and rs42651398), 22 (rs109747337 and rs110942101), and 26
(rs110747207). Five of these identified SNPs are within genes with known functions:
rs110866336 is within HS6ST3 (heparan sulfate 6-O-sulfotransferase 3), rs110804434
is within TMEM189 (transmembrane protein 189), rs41831243 is within FBXW7 (F-box
and WD repeat domain containing 7), rs111021268 is within FSD2 (fibronectin type III
and SPRY domain containing 2), and rs110942101 is within CCR4 (C-C motif
chemokine receptor 4).
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Table 2: Identified loci associated with developed novel phenotypes.
Trait

rs

Locus
1
(Chr: bp)

SNP type

Allele
2
Frequencies

Nearest gene(s)

Prior Evidence

P-value

Loci with prior evidence
-6

7.64x10

-6

7.64x10

-6

SCS QTL
(Schulman et al.,
2004)

7.64x10

-6

NHLH2, CASQ2

MY QTLs
(Viitala et al., 2003,
Ashwell et al., 2004)

3.10x10

-5

A: 0.48 G: 0.52

ZNF696

MY QTLs, SCS QTL
(Viitala et al., 2003,
Ashwell et al., 2004)

3.65x10

-5

3’ downstream

A: 0.78 G: 0.22

TMEM182

4.27x10

-5

14: 4,468,478

Intron variant

A: 0.40 G: 0.60

TRAPPC9

7.04x10

-5

15: 25,622,211

Intron variant

A: 0.50 C: 0.50

LOC101908225

SCS QTL
(Boichard et al., 2003)

7.75x10

-5

17: 5,221,649

Intron variant

C: 0.08 T: 0.92

FBXW7

--

2.68x10

-6

rs41665257

9: 4,581,947

5’ upstream

C: 0.08 T: 0.92

LOC104968410

7d AUC

rs43709346

3: 74,836,184

intergenic

A: 0.98 G: 0.02

PTGER3, CTH

7d AUC

rs43423752

5: 2,925,015

3’ downstream

C: 0.98 T: 0.02

TRHDE

7d AUC

rs111021268

21: 23,530,389

Intron variant

C: 0.95 T: 0.05

FSD2

7d AUC

rs109880729

3: 27,600,325

Intergenic

C: 0.05 T: 0.95

Severity
Score

rs110199901

14: 2,524,432

Intron variant

rs41610542

11:7,625,345

st

S. uberis 1
clearance

Severity
rs55617160
Score
S. uberis
shedding
rs109427689
cycles
Newly identified loci

CM QTL
(Lund et al., 2008)
CM QTL
(Klungland et al.,
2001)
MY QTL
(Daetwyler et al.,
2008)

6.56x10

7d AUC

SCC QTL
(Schnabel et al.,
2005)
MY QTL, SCS QTL
(Kaupe et al., 2007)

7d AUC

rs41831243

7d AUC

rs110804434

13: 78,901,415

Intron variant

A: 0.41 G: 0.59

TMEM189*

--

4.96x10

-6

7d AUC

rs110866336

12: 77,746,796

Intron variant

A: 0.78 G: 0.22

HS6ST3

--

5.21x10

-6

7d AUC

rs109747337

22: 58,790,629

Intergenic

A: 0.93 G: 0.07

CHCHD4, WNT7A

--

9.39x10

-6

♦
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Table 2: Continued
Trait

rs

7d AUC

rs109290019

~

Locus (Chr:
1
bp)

SNP type

Allele
2
Frequencies

Nearest gene(s)

Prior Evidence

P-value

18: 53,260,898

Intergenic

A: 0.57 G: 0.43

TRAPPC6A,
EXOC3L2

--

1.94x10

-5

Chronic
Score
Severity
Score
7d AUC

rs43273037

1: 134,069,561

Intron variant

G: 0.59 T: 0.41

PCCB

--

2.00x10

-5

rs109788678

13: 11,784,421

Intron variant

C: 0.67 T: 0.33

CAMK1D

--

2.40x10

-5

rs42651398

21: 39,716,280

3’ downstream

C: 0.49 T: 0.51

FOXG1

--

2.46x10

-5

7d AUC

rs110942101

22: 7,385,040

Intron variant

G: 0.07 T: 0.93

CCR4

--

3.10x10

-5

7d AUC

rs109070561

18: 53,281,931

Intron variant

A: 0.46 G: 0.54

LOC508455

--

3.96x10

-5

rs110804434

13: 78,901,415

Intron variant

A: 0.41 G: 0.59

TMEM189*

--

4.52x10

-5

rs41645172

2: 109,778,246

5’ upstream

A: 0.69 G: 0.31

EPHA4

--

5.74x10

-5

♦

28d AUC
st

S. uberis 1
clearance
S. uberis
shedding
cycles
7d AUC

rs41576873

4: 92,742,789

Intron variant

A: 0.62 G: 0.38

SND1

--

6.12x10

-5

rs110974478

1: 150,141,293

Intergenic

A: 0.09 G: 0.91

SETD4, CBR3

--

6.15x10

-5

28d AUC

rs110693161

24: 48,872,488

Intron variant

A: 0.20 G: 0.80

CTIF

--

6.73x10

-5

S. uberis 1
clearance

rs41653441

28: 28,149,081

Intron variant

C: 0.51 T: 0.49

PSAP*

--

7.04x10

-5

7d AUC

rs110747207

26: 50,933,887

Non-coding
transcript
variant

A: 0.17 G: 0.83

LOC100850437

--

7.14x10

-5

S. uberis
shedding
cycles

rs41570578

17: 64,142,204

Intron variant

G: 0.70 T: 0.30

HECTD4

--

7.47x10

-5

28d AUC

rs109290019

18: 53,260,898

Intergenic

A: 0.57 G: 0.43

TRAPPC6A,
EXOC3L2

--

8.91x10

-5

Chronic
Score

rs110599808

28: 247,173

Intron variant

A: 0.43 G: 0.57

RAB4A

--

9.70x10

-5

st

~

1

Reported positions are based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build.
Allele frequencies are representative of the current study population.
*Gene is a partial start transcript
♦~
Indicate SNPs identified using more than one novel phenotype, each symbol is unique to one rs number.
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Figure 6: Minimum, median, and maximum for S. uberis 1st clearance, severity score,
and chronic score phenotypes. S. uberis 1st clearance is represented by the number of
days until S. uberis CFU reached zero based on milk culturing. Severity and chronic
scores are represented by the sum of milk and mammary scores over the initial 7 d
post-challenge or the entire 28 d challenge period, respectively. Minimums for both
severity and chronic score were zero.
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Figure 7: Manhattan plot of GWAS for S. uberis 1st clearance phenotype using
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34). The x-axis
shows chromosome and SNP order within a chromosome. The y-axis show the –
log10(P-value) for each SNP. P-value thresholds are indicated by dashed lines: top
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5.
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Figure 8: Number of cows per S. uberis shedding cycle category, where the x-axis
indicates the number of times S. uberis CFU reached zero within the 28 day sampling
period.
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Figure 9: Manhattan plot of GWAS for S. uberis shedding cycles phenotype using
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34). The x-axis
shows chromosome and SNP order within a chromosome. The y-axis show the –
log10(P-value) for each SNP. P-value thresholds are indicated by dashed lines: top
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5.
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Figure 10: Minimum, median, and maximum S. uberis CFU AUC values for both 7 and
28 d phenotypes displayed in millions of CFU*d.
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Figure 11: Manhattan plot of GWAS for 7 d S. uberis CFU AUC phenotype using
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36). The x-axis
shows chromosome and SNP order within a chromosome. The y-axis show the –
log10(P-value) for each SNP. P-value thresholds are indicated by dashed lines: top
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5.
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Areas under the curve for the 28 day time period ranged from 38.5 CFU*d to
1.27x108 CFU*d, with a median of 5.55x107 CFU*d (Figure 10). Association analyses
identified 3 suggestively significant (p < 9.34x10-5) associated with 28 d S. uberis AUC
(Figure 12). Two of the identified SNPs (rs110804434 on BTA 15 and rs109290019 on
BTA 18) were also identified using the 7d AUC phenotype. The remaining identified
SNP (rs110693161) is on BTA 24 and located within the CTIF (cap binding complex
dependent translation initiation factor) gene.
The next two phenotypes were generated using sums of mammary and milk
scores to identify levels of inflammation. Severity score focused on cows displaying
acute clinical signs post-challenge by summing their scores for the first 7 days after
challenge. Severity scores ranged from 0 to 50, with a median of 43 (Figure 6).
Analyses identified 3 suggestively significant (p < 9.34x10-5) SNPs associated with
severity score located on BTAs 13 (rs109788678), 14 (rs110199901 and rs55617160)
(Figure 13). All three SNPs are within genes with known functions. The BTA 13 SNP,
rs109788678, is within the CAMK1D (calcium/calmodulin dependent protein kinase 1D)
gene. The SNPs on BTA 14, rs110199901 and rs55617160 are within the ZNF696
(zinc finger protein 696) gene and the TRAPPC9 (trafficking protein particle complex 9)
gene, respectively. Chronic score focused on chronically symptomatic cows by
summing scores across the entire 28 day sampling period. Chronic scores ranged from
0 to 71 and had a median of 54.5 (Figure 6). Chronic score identified 2 suggestively
significant SNPs (p < 9.34x10-5), with one SNP each on BTA 1 (rs43273037) and 28
(rs110599808) (Figure 14). Both SNPs are within known genes; rs43273037 is located
within the PCCB (Propionyl CoA carboxylase, beta polypeptide) gene and rs110599808
is within the RAB4A (RAB4A, member RAS oncogene family) gene.
Discussion
This study successfully identified associations between SNPs in the bovine
genome and novel phenotypes generated from data obtained using an S. uberis
challenge model. Our prior study (Siebert Dissertation, Chapter 3) utilized the same
study design to develop SCC based phenotypes and successfully identified 16 SNPs,
where 4 SNPs were located directly in potential candidate genes, 3 more SNPs were in
quantitative trait loci (QTLs) previously linked to mastitis or mastitis related phenotypes,
and 2 more SNPs within candidate genes and previously identified QTLs. The success
of our prior study helps lend strength to the results of the present study. Additionally, 9
of the SNPs identified in this study (rs41665257, rs43709346, rs43423752,
rs111021268, rs109880729, rs110199901, rs41610542, rs55617160, and rs109427689)
are located in genomic regions with prior evidence associated with mastitis or related
phenotypes. Considering both our studies successfully identified genomic
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Figure 12: Manhattan plot of GWAS for 28 d S. uberis CFU AUC phenotype using
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35). The x-axis
shows chromosome and SNP order within a chromosome. The y-axis show the –
log10(P-value) for each SNP. P-value thresholds are indicated by dashed lines: top
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5.
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Figure 13: Manhattan plot of GWAS for severity score phenotype using BovineSNP50
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 36). The x-axis shows
chromosome and SNP order within a chromosome. The y-axis show the –log10(Pvalue) for each SNP. P-value thresholds are indicated by dashed lines: top black line p
= 1.95x10-5; bottom gray line p = 9.34x10-5.
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Figure 14: Manhattan plot of GWAS for chronic score phenotype using BovineSNP50
v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 34). The x-axis shows
chromosome and SNP order within a chromosome. The y-axis show the –log10(Pvalue) for each SNP. P-value thresholds are indicated by dashed lines: top black line p
= 1.95x10-5; bottom gray line p = 9.34x10-5.
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regions with prior evidence linked to mastitis or traits associated with mastitis, the use of
novel phenotypes derived from S. uberis challenge data to identify genomic regions of
interest for S. uberis mastitis may be a viable new method for identifying candidate
genes.
Of the identified SNPs in the present study, two SNPs associated with the 7d
AUC phenotype (rs41665257 and rs43709346) were located within QTLs for clinical
mastitis (CM) (Klungland et al. 2001; Lund et al. 2008). Clinical mastitis is hallmarked
by mammary gland inflammation and altered milk production. The inflammation
associated with CM typically indicates a strong immune response correlating to higher
recruitment of SCC. Higher SCC could lead to faster clearance of S. uberis from the
gland and lead to lower observed 7d AUC phenotypes. Another 5 SNPs significantly
associated with the phenotypes S. uberis first clearance (rs41610542), S. uberis
shedding cycles phenotype (rs109427687), 7d AUC (rs111021268), and severity score
(rs110199901 and rs55617160) were located within QTLs associated with SCC and
SCS (Ashwell et al. 2004; Boichard et al. 2003; Kaupe et al. 2007; Schnabel et al. 2005;
Schulman et al. 2004). More elevated SCC/SCS would indicate more immune cells to
fight the infection and would likely correlate to faster bacteria clearance post-challenge
linking SCC/SCS directly to our S. uberis 1st clearance and 7d AUC phenotypes. The
more elevated SCC/SCS and subsequent faster bacteria clearance would also lead to
more inflammation observed and higher mammary and milk scores which ties SCS to
our severity score phenotype. Conversely, lower SCC/SCS would indicate fewer
immune cells to fight the infection and potentially allow for the infection to persist, or
even demonstrate cycling of bacteria clearance when the immune cell populations are
depleted and more haven’t yet reached the gland, which links SCS to our S. uberis
cycles phenotype. Of interest, SNPs associated with 7d AUC (rs43423752 and
rs109880729) and severity score (rs110199901 and rs55617160) phenotypes were
located in regions previously identified as associated with milk yield (MY) QTLs (Ashwell
et al. 2004; Daetwyler et al. 2008; Kaupe et al. 2007; Viitala et al. 2003). The
association of mastitis incidence and milk yield has been known for decades (Meredith
et al. 2012; Shaw and Beam 1935; Wilson et al. 1997) since fighting infections
sequesters energy that would otherwise be partitioned to milk production. Since, higher
S. uberis CFU would lead to higher SCC (used as an indicator of mastitis) and higher
SCC causes higher mammary and milk scores, both 7d AUC and severity score could
impact MY.
While the identified SNPs themselves may not be causal but rather in linkage
disequilibrium is the causal variant, they do provide several interesting candidate genes
based on the genes they are located within. Of the SNPs identified with prior evidence,
74

3 are also within known genes. First, rs111021268, identified with the 7d AUC
phenotype, is located within the FSD2 (fibronectin type III and SPRY domain containing
2) gene. While there is not a specific known function for FSD2, the domains it contains
(FN3 and SPRY) are components of many other proteins. The FN3 domain is an
extracellular free-acting domain that provides a scaffold for the binding of a variety of
ligands (Bloom and Calabro 2009; Campbell and Spitzfaden 1994). The SPRY domain
is intracellular and is also involved in protein interactions, including those that regulate
the innate and adaptive immune systems through transcriptional regulation and
production of reactive compounds (D'Cruz et al. 2013). Inabilities to properly interact
with ligand and/or mount an effective immune response would permit S. uberis growth
in the mammary gland and lead to higher 7d AUC phenotypes observed.
The other two SNPs with prior evidence and within genes were identified using
the severity score phenotype. Within the ZNF696 (zinc finger protein 696) gene is the
rs110199901SNP. While no specific function is attributed to ZFN696, zinc finger
proteins are frequently involved in DNA/RNA binding and subsequent regulation of
transcription/translation (Laity et al. 2001). Lastly, rs55617160 is within the TRAPPC9
(trafficking protein particle complex 9). TRAPPC9 has been linked to increased
cytokine-mediated NFĸB activation through phosphorylation of the IKK complex (Hu et
al. 2005). NFĸB is a transcriptional activator of many genes including many that are
critical for inflammation and immunity (Bonizzi and Karin 2004). The inability to properly
regulate transcriptional and/or translational changes following an infection would likely
result in lower observed inflammation and reduced immune responses despite bacteria
presence, leading to the lower severity score phenotypes observed.
The S. uberis 1st clearance phenotype identified 2 novel SNPs, one SNP
(rs41645172) on BTA 2 at 109.8Mb, and another SNP (rs41653441) on BTA 28 at
28.1Mb that is within the PSAP (prosaposin) gene. Prosaposin is the precursor that
generates saposin A, B, C, and D through limited proteolytic processing (O'Brien and
Kishimoto 1991). Saposins are involved in lipid degradation within the lysosome and
also play a role in loading lipid antigens onto CD1 molecules (Barral and Brenner 2007).
Antigen presentation by CD1 activates several sub-sets of T-cells, including CD8+ Tcells which have demonstrated importance in for killing S. uberis in the mammary gland
(Barral and Brenner 2007; Denis et al. 2011). Additionally, the un-cleaved prosaposin
precursor may play a role in regulating cell proliferation and apoptosis (Sun et al. 2010).
Thus, PSAP could play a role eliciting a more efficient response to and clearance of
invading pathogens and lead to lower observed S. uberis 1st clearance phenotype.
The S. uberis cycles phenotype identified two other novel SNPs in genes, one
SNP (rs41576873) on BTA 4 at 92.7Mb and another SNP (rs41570578) on BTA 17 at
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64.1Mb. The BTA 4 SNP is within the SND1 (staphylococcal nuclease and tudor
domain containing 1) gene. SND1 is a transcriptional coactivator that interacts with
many other transcriptional activators including STAT5 and STAT6 (Yang et al. 2002;
Yang et al. 2007). STAT5 plays a role in preventing apoptosis of lymphocytes (Mui et
al. 1995). STAT6 is involved in IL-4 signal transduction to differentiate naïve t-helper
cells into Th2 cells that are essential for activating the humoral (B-cell) response
(Takeda et al. 1997). Reduced lymphocyte survival and humoral response could result
in fewer immune cells to fight infection. Fewer immune cells to fight infection could lead
to a cycling of bacteria clearance when immune cell populations are depleted or
unprimed with antigen leading to higher numbers of S. uberis cycles observed. The
BTA 17 SNP is within the HECTD4 (HECT domain E3 ubiquitin protein ligase 4) gene.
The HECT domain subfamily of a ubiquitin ligase protein helps determine the type of
ubiquitin chain formed during ubiquination (Sheng et al. 2012). Ubiquination helps
determine the biological fates of protein by targeting them for degradation, altering their
cellular location, or affecting their interactions/ activity (Glickman and Ciechanover
2002; Schnell and Hicke 2003). Ubiquination has been demonstrated to control the
immune response through NFĸB regulation, thus alterations in HECT domains could
result in altered NFĸB regulation and subsequent altered immune response (Magnani et
al. 2000). Alterations in immune response could alter S. uberis’s ability to proliferate
within the gland and possibly allow for bacterial clearance cycling as other aspects of
the immune system attempt to compensate for those ubiquination may affect.
The 7d AUC phenotype identified the most SNPs when compared to other
phenotypes, with 10 SNPs being novel. Four of these novel SNPs are located in genes
with known functions. One SNP, rs41831243, on BTA 17 at 5.2Mb, is in the FBXW7 (Fbox and WD repeat domain containing 7) gene. FBXW7 is a subunit of the SCF
ubiquitin protein ligase complex that targets mediators of the cell cycle and cell division
using phosphorylation-dependent ubiquination. Specifically, FBXW7 is critical for
immature CD4+CD8+ T-cells to exit the cell cycle and for the proliferation of mature Tcells (Onoyama et al. 2007). Since CD8+ T-cells have demonstrated particular
importance in for killing S. uberis in the mammary gland (Barral and Brenner 2007;
Denis et al. 2011), inadequate T-cell maturation and proliferation could permit S. uberis
to persist in the gland post-challenge and lead to higher the 7d AUC phenotypes
observed. Another SNP on BTA 13 at 78.9Mb, rs110804434, also identified with the
28d AUC phenotype, is within the TMEM189 (transmembrane protein 189) gene.
TMEM189 is closely downstream to UBE2V1 (ubiquitin-conjugating enzyme E2 variant
1) and the two genes are often expressed as a conjoined gene (Prakash et al. 2010).
While there is no known function tied to the conjoined genes, it is hypothesized they
play a role in gene regulation (Prakash et al. 2010). Additionally, overexpression of this
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particular conjoined gene has been linked to slower degradation of other (EGF) receptor
complexes via endocytosis (Duex et al. 2010). Therefore, TMEM189 could help
regulate gene expression and receptor-ligand complex degradation during the infection
process and lead to higher or lower observed 7d and 28d AUC observed phenotyped
depending on the effect. The third SNP identified with 7d AUC, rs110866336, at
77.7Mb on BTA 12, is in the HS6ST3 (heparan sulfate 6-O-sulfotransferase 3) gene.
HS6ST3 modifies heparan sulfate, found in heparan sulfate proteoglycans on the cell
surface and in the extracellular matrix, to generate a variety of structures needed for
protein interactions (Habuchi et al. 1995; Yanagishita and Hascall 1992). Such protein
interactions have demonstrated importance for both inflammation and bacteria
adherence/infection (Rostand and Esko 1997; Tanaka et al. 1993). Therefore, a
reduction of modified heparan sulfates would likely lead to less inflammation and
reduced bacterial adherence/infection and probably correlate with lower 7d AUC
phenotypes. The final SNP (rs110942101) within a gene for 7d AUC is on BTA 22 at
7.4Mb and is within the CCR4 (C-C motif chemokine receptor) gene. CCR4 is the gprotein coupled receptor for chemokine CCL22, which is released by macrophages
upon the initiation of immune responses (Imai et al. 1998). CCR4 is expressed on both
CD4+ and CD8+ T-cells and its expression is upregulated after activation (i.e.: ligand
binding) (D’Ambrosio et al. 1998). Receptor-ligand complexes helps increase
extravasation, cell migration, and effector T-cell positioning at the recruitment site
(Chang et al. 1997; D’Ambrosio et al. 1998). During mastitis, significant increases in Tcell recruitment to the gland has been observed and CD8+ T-cells have demonstrated
specific and substantial killing ability towards S. uberis (Denis et al. 2011; Mehrzad et al.
2008). Thus, alterations in CCR4 could correlate to faster clearance of invading
bacteria in the mammary gland and lower observed CFU leading to lower 7d AUC
phenotypes observed.
The 28d AUC phenotype identified 3 novel SNPs. Both rs109290019 and
rs110804434 were also identified by 7d AUC phenotype and were discussed previously.
The third SNP, rs100693161, located on BTA 24 at 48.9Mb, is located within the CTIF
(cap binding complex dependent translation initiation factor) gene. CTIF is a
component of the CBP80/20-dependent translation initiation complex that cotranscriptionally binds the cap end of nascent mRNAs (Kim et al. 2009). The CBP80/20
complex recognizes premature termination codons (PTCs) during translation which
helps minimize expression of truncated proteins by targeting them for decay (Chang et
al. 2007). A mutation in CTIF could permit a breakdown in this editing process allowing
a higher expression of truncated proteins that are either non-functional or toxic to host
cells, which depending on the effected proteins, could permit more growth of S. uberis
and lead to higher observed 28d AUC phenotypes.
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The severity score phenotype identified only one novel SNP located on BTA 13
at 11.8Mb and within the CAMK1D (calcium/calmodulin dependent protein kinase 1D)
gene. CAMK1D is a component of the calcium-regulated calmodulin-dependent protein
kinase cascade which has been implicated in the migration of neutrophils following
chemoattractant stimulation (Verploegen et al. 2002). Inefficiencies in stimulating
neutrophil migration would lead to lower levels of inflammation observed at the site of
infection and result in the observation of lower severity score phenotypes.
Both of the novel SNPs identified by the chronic score phenotype are located
within genes. Within the PCCB (propionyl CoA carboxylase, beta polypeptide) gene, on
BTA 1 at 134.1Mb, is rs43273037. PCCB is a subunit of propionyl CoA carboxylase
which is involved in the metabolism of propionic acid that has no definitive connections
to the chronic score phenotype (Tietz and Ochoa 1959). However, propionic acid is one
of the main energy sources used by dairy cattle and energy status has demonstrated
importance for susceptibility to mastitis (Knegsel et al. 2005; Rezamand et al. 2007).
Thus, reduced ability to metabolize propionic acid could decrease available energy and
influence susceptibility to mastitis and potentially allow for infections to persist and
cause increased chronic scores observed. Lastly, rs110599808 is on BTA 28 at 0.2Mb
and is in the RAB4A (RAB4A, member RAS oncogene family) gene. RAB4A is a
member of the RAS superfamily of small GTPases that are involved in regulating
membrane trafficking. Specifically, RAB4A regulates the secretion of α-granules from
platelets (Shirakawa et al. 2000). Platelet α-granules contain P-selectin which is a vital
cell adhesion molecule needed for monocyte and neutrophil extravasation which is
required for cell recruitment to the site of infection (Furie et al. 2001). Improper
extravasation would result in fewer immune cells at the infection site and result in lower
levels of inflammation and lower chronic scores observed.
In conclusion, this study was successful in identifying SNPs associated with
novel phenotypes generated from data collected following direct S. uberis experimental
challenge. Considering 31% of the SNPs identified using our novel phenotypes are in
regions with prior evidence linked to mastitis, the probability that our remaining identified
loci are valid associations is high. The majority of the identified SNPs are also located
within known genes where 17% have functions linked to immune functions and 28%
have roles in the regulation of gene or protein expression. Associations with immune
function and gene regulation are logical since recognition of S. uberis within the
mammary gland would cause the upregulation of many genes, especially those linked to
immune processes. Thus, the investigation of these candidate genes could potentially
uncover novel treatment or preventative strategies for S. uberis mastitis or serve as
selections markers for cows less susceptible to S. uberis mastitis. Furthermore, the
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possibility that these genes could be associated with other causative pathogens exists
since the identified genes seem to have links to more generic immune processes rather
than to S. uberis’s unique pathology.
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Abstract
Mastitis is a detrimental disease in the dairy industry that costs upwards of $2
billion annually and decreases milk quality. Often, mastitis results from bacteria
entering the gland through the teat end. A common mastitis causing pathogen is S.
uberis, which is responsible for a high percentage of subclinical and clinical mastitis
cases. Following an intramammary experimental challenge with S. uberis on Holstein
cows (N=40), differing phenotypes with respect to S. uberis counts, inflammation
indicators, and antibiotic therapies were observed depending on the CXCR1 haplotype
combination of the cow. However, phenotypic differences are suspected to have other
genetic influences. To test this both linkage and association tests were performed to
identify other candidate genes. Linkage analysis was performed in Haploview and
identified that the CXCR1 gene is within 2 haplotype blocks, blocks 413 and 414. Block
413 contains only the 3’ end of CXCR1 (rs43323012 and 43323013). Block 414, which
contains the 5’ end of the CXCR1 haplotype combinations (rs211042414 and
rs208795699) also contains another 21 genes that the CXCR1 SNPs could be serving
as markers for. To identify loci of interest a 50K SNP chip analysis was performed
using the BovineSNP50 v2 DNA BeadChip from Illumina. Associations were tested
using Plink and identified 7 significant (p < 9.34x 10-5) SNPs outside of the CXCR1
haplotype blocks. One of the identified SNPs is within a gene with known function and
three more are within a previously identified QTL for productive life. The identified loci
should be further investigated to potentially identify causation behind the observed
phenotypes. Such investigations could lead to novel treatment and prevention
compounds/protocols for S. uberis mastitis or genetic selection methods for cows with
greater potential to resist S. uberis infection.
Introduction
Mastitis is a devastating disease to the dairy industry that affects 20-50% of
cows, causing increases in cow morbidity/mortality, decreased milk quality, and
decreased farm revenues (Akers and Nickerson 2011; Barbano et al. 1991; Bradley et
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al. 2007; Klei et al. 1998; Ma et al. 2000; Piepers et al. 2007). Invasion of bacteria into
the mammary gland through the teat end is typically what causes mastitis. One of the
most common mastitis causing pathogens is Streptococcus uberis. S. uberis causes
roughly 14-26% of all the subclinical and clinical incidences of mastitis and is the most
commonly isolated pathogen during the dry (non-lactating) period (Bradley et al. 2007;
Petrovski et al. 2011; Verbeke et al. 2014). S. uberis is especially problematic
because, while it typically originates as an environmental pathogen, it can spread
throughout the herd in a contagious manner once introduced (Zadoks 2007).
Additionally, S. uberis has some unique pathology characteristics that can make
clearing the infection from the mammary gland more problematic. Once S. uberis
enters the mammary gland, it binds lactoferrin, which is a common milk protein (Fang
and Oliver 1999). Lactoferrin can then act as a bridging molecule and allow binding of
S. uberis to the mammary epithelial cells (Fang et al. 2000). After binding, S. uberis
then invades the host cells via caveolae dependent endocytosis (Almeida and Oliver
2006; Matthews et al. 1994). Once internalized, S. uberis can exploit host cell
transduction and persist in the cytoplasm for hours (Almeida et al. 2000; Tamilselvam et
al. 2006) effectively evading the host immune system. Since S. uberis mastitis is a
common problem dairy producers combat and S. uberis has mechanisms to evade the
immune response, identifying specific genes involved in S. uberis pathogenesis could
prove beneficial for the control and prevention of S. uberis mastitis on dairy farms.
Once in the gland, bacteria encounter several cell types including alveolar and
ductal epithelial cells that are responsible for synthesizing and secreting milk,
fibroblasts, and resident immune cells (i.e.: macrophages, dendritic cells, neutrophils).
The encountered host cell types release immune mediators in response to recognition
of bacterial presence. Immune mediators can include, but are not limited to: growth
related oncogene (GRO)-γ, epithelial-derived neutrophil-activating peptide (ENA)-78,
and interleukin (IL)-8 (Baggiolini and Clark-Lewis 1992; Rainard et al. 2008; Walz et al.
1991). The released immune mediators initiate the visual signs associated with
mastitis, such as udder inflammation and altered milk production (i.e.: reduced volume,
clots, etc.). Specifically, IL-8, upon binding its receptors CXCR1 and CXCR2, can
induce migration of immune cells to the site of infection, cause increased cell survival,
and modify chemokine/cytokine production (Grob et al. 1990; Kettritz et al. 1998;
Shamaladevi et al. 2009; Takata et al. 2004). These functions influence the rate of
response to infection and are critical to resolution of infections like mastitis.
Furthermore, associations between single nucleotide polymorphisms (SNPs) in the IL-8
receptor, CXCR1 gene and mastitis have been identified (Galvão et al. 2011; Grosse et
al. 1999; Leyva-Baca et al. 2008; Verbeke et al. 2012; Youngerman et al. 2004). Some
of the identified SNPs have also been associated with diminished migration, binding of
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secondary mediators, and receptor internalization following IL-8 binding (Fan et al.
2002; Fan et al. 2000; Raman et al. 2010; Rambeaud et al. 2006; Rambeaud and
Pighetti 2007; Rambeaud and Pighetti 2005; Yang et al. 1999). Within the coding
sequence of the CXCR1 gene, there are 5 SNPs (+365 (rs211042414), +621
(rs135751317), +735 (rs208795699), +980 (rs43323012), and +995 (rs43323013)) that
allowed for the identification of three dominant amino acid haplotypes (VWHKH,
VWHRR, AWQRR) (Pighetti et al. 2012).
A recent S. uberis challenge study demonstrated that Holstein cows (N=40)
displayed differing phenotypes with respect to S. uberis counts, inflammation indicators,
and antibiotic therapies depending on the CXCR1 haplotype combination of the cow
(Siebert 2013). However, we suspect that the observed differences in phenotype
following challenge could have other genetic influences. Other genetic influences could
include loci in linkage disequilibrium with the previously identified CXCR1 SNPs or loci
throughout the genome that work together with CXCR1 pleiotropically. To test for
genetic influences, we will identify the haplotype block surrounding the bovine CXCR1
gene and perform an association analysis using a phenotype which includes genetic
CXCR1 haplotype combination with antibiotic therapy grouping following intramammary
S. uberis experimental challenge. This approach will identify genes that are in linkage
disequilibrium with CXCR1 and genes that could be working pleiotropically with CXCR1
throughout the genome that could be influencing the different phenotypes observed
following S. uberis challenge in our prior study (Siebert 2013). Both approaches will
identify other candidate genes that can be investigated for potential novel preventative
or treatment compounds or improved genetic selection methods for cows less
susceptible to S. uberis mastitis.
Materials and Methods
Animal Selection
Holstein dairy cows (N = 40) that were entering their second or third lactation
were enrolled in a trial to test the effectiveness of a novel vaccine candidate against S.
uberis, i.e.: Streptococcus uberis adhesion molecule (SUAM) that involved a direct S.
uberis challenge (USDA-NIFA AFRI 2011-67015-30168). Cows were in overall good
health, pregnant, at the end of their first or second lactation, had quarter SCC <250,000
cells/mL, and were free of Johne’s, brucellosis, tuberculosis, and bovine leukemia virus
(BLV). Both S. uberis and SUAM baseline titers were assessed and cows with the
lowest titers were enrolled. All cows were housed at the East Tennessee Education
and Research Center (ETREC) Little River Dairy (Walland, TN). Upon arrival at
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ETREC, cows were acclimated to the facility for two weeks prior to the initiation of
research protocols. Cows were housed separately from the core herd and cared for in
accordance with ETREC Little River Dairy standard protocols. All animal based work
was approved by and done in accordance with Institutional Care and Use Committee
(IACUC) guidelines.
Haplotyping
Blood samples (n=1 for each cow), collected during the dry period via jugular
puncture, were used to isolate DNA with UltraClean BloodSpin DNA Isolation Kit (Mo
Bio, Carlsbad, CA). The SNP containing portion of the CXCR1 gene was amplified as
follows: 1-2 ng of bovine genomic DNA was used as template in a 25 µl reaction
containing specific primers (Forward: 5’-CTTCATC-TTCCGGTGAGGCCTATCAAC-3’;
Reverse: 5’-AAGGGAAGGGGACTTTCCTGGCTG-3’) and Eppendorf HotMaster Mix
(Eppendorf North America; Westbury, NY) according to manufacturer's guidelines. DNA
concentration was confirmed via spectrophotometry using NanoDrop 1000 (Thermo
Fisher Scientific; Wilmington, DE). Conditions for amplification were: an initial hot-start
denaturation at 94oC for 2 min, followed by 50 cycles of 94oC denaturation for 15 s,
62oC annealing for 20 s, and 72oC extension for 60 s. After the last cycle, a 10 min final
extension step at 72oC was added before reactions were chilled to 4oC. Amplified
products were purified to remove primer and excess nucleotides. The resulting purified
CXCR1 DNA was sequenced using bovine CXCR1 specific primers (Forward: 5’CTTCATC-TTCCGGTGAGGCCTATCAAC-3’; Reverse: 5’AAGGGAAGGGGACTTTCCTGGCTG-3’) and the CXCR1 haplotype, comprised of
positions +365 (rs211042414), +621 (rs135751317), +735 (rs208795699), +980
(rs43323012), and +995 (rs43323013), was determined based on nucleotide expression
at tagSNP positions +621 (rs135751317), +735 (rs208795699), +816 (rs210501501),
and +980 (rs43323012) in the CXCR1 gene previously identified using phasing on a
larger population (Pighetti et al. 2012; Stephens and Scheet 2005; Stephens et al.
2001). Within the haplotype combination groups: VWHRR x VWHRR cows did not
share any parentage back three generations; VWHKH x VWHRR, AWQRR x VWHRR,
and AWQRR x VWHKH groups each had two cows sharing a grandsire, which was the
same grandsire for each haplotype combination; and AWQRR x AWQRR cows were the
most related group, with two pairs of cows sharing sires, one pair of cows sharing a
maternal grandsire, and one set of three cows sharing a paternal grandsire.
Challenge
Approximately one week prior to calving and at first milking post-calving,
secretion samples were collected from each quarter to screen for bacterial presence to
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select a challenge quarter free of pathogens. A frozen stock of Streptococcus uberis
(UT888) was thawed in a 37°C water bath and an aliquot used to inoculate a blood agar
plate. After 23-24 h of growth on the agar, 3 representative colonies were used to
inoculate Todd Hewitt Broth for an additional 7 h of growth. The 1 mL aliquot of the
resulting liquid culture was serially diluted in PBS to approximately 2,000 CFU for
infusion. A total of 5 mL of the diluted culture was used for challenge, resulting in a total
of 10,000 CFU delivered. Challenge was performed within 3 days post-calving
immediately following milking. Prior to intramammary infusion, teat ends were cleaned
thoroughly with sterile alcohol pads and the inoculum was infused using sterile
disposable syringes with teat cannulas. The challenge inoculum was massaged upward
into the teat and gland cisterns and plated (100μL) to determine the actual CFU/mL of
S. uberis delivered which averaged 2122 ± 371 CFU/mL and ranged from 1185 to 3202
CFU/mL.
Sampling and Phenotype Description
Cows were closely monitored post-challenge for the development of mastitis for
28 d post-challenge. Mammary and milk scores were evaluated on a 0 to 3 scale by
ETREC Little River Staff twice daily. Mammary scores were defined as follows: 0 =
normal, 1 = slight swelling, 2 = moderate swelling, 3 = edema. Milk scores were defined
as follows: 0 = normal, 1 = small flakes or clots, 2 = large clots, 3 = stringy, off color,
watery, or bloody. Cows with 3 consecutive sets of severe scores (a 2 in both
mammary and milk or a 3 in either) were treated with antibiotics. Alternatively, if cows
were still shedding S. uberis 14 d post-challenge, antibiotics were administered to clear
the infection, since the end goal was to return healthy cows back to the general milking
herd. Following the 28 d sampling period, the percentage of cows within each CXCR1
haplotype combination that required antibiotics to clear the infection was determined.
This resulted in 3 percentage groups used to test for associations: 100% antibiotic
therapy (VWHRR x VWHRR and AWQRR x VWHRR), 75% antibiotic therapy (AWQRR
x VWHKH and AWQRR x AWQRR), and 33% antibiotic therapy (VWHKH x VWHRR).
The haplotypes of two cows, 222 and 237, could not be determined and were not
included in response variable analyses, resulting in N=38 cows.
Association and Linkage Analysis
Blood samples were collected from each cow via jugular puncture and DNA was
isolated using UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).
Resulting DNA was used to perform a 50K SNP chip analysis using the BovineSNP50
DNA Analysis BeadChip (Illumina, San Diego, CA) (Gunderson et al. 2005; Steemers et
al. 2006). The SNP chip has 54,609 SNPs that span all 29 autosomes of the bovine
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genome with an average SNP spacing of 49.4kb and a median spacing of 36.9kb.
Associations were tested between developed the phenotype and SNPs using Plink
(Purcell et al. 2007). Effects of sex were excluded from the analysis because all
individuals were female and SNPs did not represent sex chromosomes. The p-value
cutoffs of p < 1.95x10-5 for highly significant SNPs and p = 1.95x10-5 to 9.34x10-5 for
suggestively significant SNPs were set based on guidelines for reducing false positives
and increasing reproducibility (Manly 2005). For identified SNPs to be reported, the
minor allele had to be represented by more than one cow, unless the SNP aligned with
prior evidence for mastitis or mastitis related traits. A complete index of identified
SNPs, including those removed based on the minor allele criteria, is included as an
appendix (Table A-1). To allow depiction of the numerous SNPs, their genome
locations, and their variable association p-values, generated Plink results were
visualized using Manhattan plots created with Integrated Genome Viewer (IGV)
(Robinson et al. 2011).
For linkage analysis a subset of the 50K SNP chip data was created to include
only SNPs on BTA 2, the chromosome where the CXCR1 gene is located. Genotypes
for each of the 5 CXCR1 SNPs were added to the SNP chip dataset based on the
haplotyping results for each cow. Additionally the locations of the CXCR1 SNPs were
added to the SNP map file. Linkage analyses were performed using Haploview (Barrett
et al. 2005). SNPs were excluded from the linkage analysis when the minor allele was
not observed in the genotyped cows, which resulted in the removal of the CXCR1 +621
(rs135751317). Additionally, SNPs where less than 50% of cows were genotyped due
to poor reads were removed from analysis. After SNP editing, a total of 692 SNPs were
removed, resulting in 2,142 SNPs on BTA being included in the linkage analysis.
Haplotype blocks surrounding the CXCR1 SNPs were determined using the solid spine
algorithm such that the first and last marker in each block is in strong linkage
disequilibrium with all the intermediate markers. All reported gene and SNP locations
for both analyses were reported based on the Bos taurus UMD_3.1.1
(GCF_000003055.6) genome build.
Results
The linkage analysis identified a total of 529 haplotype blocks on BTA 2, which is
137.24 Mb in length, using solid spine linkage analysis. The CXCR1 SNPs were
included within 2 blocks, block 413 and block 414 (Table 3, Figure 15, Figure 16). Block
413 ranges from rs43323008 to rs43323012 which is 106,924,044 – 106,937,600 bp
(13kb) on BTA 2 . The only gene coded within block 413 is the 3’ end of CXCR1 which
includes SNPs rs43323012 and 43323013 (Table 4). Block 414 ranges from
rs208795699 to rs110289171 which is 106,937,845 – 107,378,666 bp (440kb) on BTA 2
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Table 3: SNPs identified to be in linkage disequilibrium with CXCR1 SNPs using
Haploview based on BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) positions.
SNP Name
Block 413 (13 kb)
ARS-BFGL-NGS-3684
CXCR1c995
CXCR1c980
Block 414 (440 kb)
CXCR1c735
CXCR1c621
CXCR1c365
BTA-48880-no-rs
BTA-48881-no-rs
Hapmap60413-ss46526389
Hapmap31750-BTA-134395
ARS-BFGL-NGS-116634
ARS-BFGL-NGS-5566

rs

BTA 2 Location

rs43323008
rs43323013
rs43323012

106,924,044
106,937,585
106,937,600

rs208795699
rs135751317
rs211042414
rs41585646
rs41585647
rs41255527
rs109464198
rs109230217
rs110289171

106,937,845
106,937,962
106,938,215
106,952,479
106,984,473
107,005,982
107,168,923
107,318,080
107,378,666
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Figure 15: Linkage analysis identifying SNPs on BTA 2 in linkage disequilibrium with
CXCR1 SNPs using BovineSNP50 v2 BeadChip (Illumina, San Diego, CA). Blocks are
outlined in thick black lines. Colors indicate likelihood of linkage disequilibrium (LD) as
calculated by logarithm of odds (LOD; log10(likelihood of LD/likelihood of equilibrium
where higher values indicate more likely LD) and D’ (disequilibrium coefficient
normalized for the observed allele frequencies; values closer to 1 or 100% indicate
higher LD; numbers in squares). Red squares = LOD ≥ 2, D’ = 1. Shades of pink =
LOD ≥ 2, D’ < 1. Blue = LOD < 2, D’ = 1. White = LOD < 2, D’ < 1; strong evidence of
recombination.
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Figure 16: Spatial diagram SNPs identified to be in linkage disequilibrium with CXCR1
SNPs using Haploview based on BovineSNP50 v2 BeadChip (Illumina, San Diego, CA)
positions.
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Table 4: Genes and RNAs contained within the haplotype blocks surrounding CXCR1
SNPs based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build.
Gene
Abbreviation
Block 413 (106,924,044-106,937,600 bp)
Bp Range

106,936,878-106,937,600

CXCR1

Gene Name

C-X-C motif receptor 1

NCBI ID

281863

Block 414 (106,937,845-107,387,666 bp)
106,937,845-106,938,583

CXCR1

C-X-C motif receptor 1

281863

106,943,692-106,949,081

LOC107131616

non-coding RNA

107131616

106,978,526-107,006,143

ARPC2

actin related protein complex, subunit 2

540838

107,011,567-107,015,000

GPBAR1

g-protein coupled bile acid receptor 1

317756

107,015,357-107,020,300

AAMP

angio-associated migratory cell protein

767919

107,020,657-107,093,550

PNKD

616561

107,023,823-107,041,372

TMBIM1

107,082,988-107,087,346

LOC104971306

107,099,749-107,106,176

CATIP

107,103,742-107,105,782

LOC104971307

107,114,929-107,125,854

SLC11A1

107,130,426-107,139,000

CTDSP1

107,133,394-107,133,478

MIR26B

paroxysmal non-kinesigenic dyskinesia
transmembrane BAX inhibitor motif
containing 1
non-coding RNA
ciliogenesis associated TTC17
interacting protein
non-coding RNA
solute carrier family 11 (proton-coupled
divalent metal ion transporter)
CTD (carboxy-terminal domain) small
phosphatase 1
microRNA 26b

107,145,511-107,169,204

VIL1

villin 1

281573

107,170,031-107,255,579

USP37

407168

107,256,013-107,289,222

RQCD1

107,294,531-107,321,327

PLCD4

ubiquitin specific peptidase 37
RCD1 required for cell differentiation 1
homolog (S. pombe)
phospholipase C, delta 4

107,322,027-107,341,857

ZNF142

zinc finger protein 142

511573

107,341,872-107,345,831

BCS1L

BCS1-like (S. cerevisiae)

539713

107,346,275-107,355,558

RNF25

ring finger protein 25

511571

107,355,281-107,387,666

STK36

serine/threonine kinase 36

508408
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404134
104971306
514380
104971307
282470
516199
MI0004745

536537
540771

and includes the 5’ end of the CXCR1 gene (rs211042414 and rs208795699). There
are a total of 17 protein coding genes, 3 non-coding RNAs, and 1 micro RNA coded
within block 414 (Table 4).
For the antibiotic therapy phenotype developed from both CXCR1 haplotype
combination and the necessity of antibiotics following challenge (Table 5, Figure 17),
the 70-75% antibiotic therapy phenotype was most common, representing N=18 cows
with both AWQRR x VWHKH and AWQRR x AWQRR haplotype combinations. The
second most common phenotype was the 100% antibiotic therapy, with N=10 cows from
both VWHRR x VWHRR and AWQRR x VWHRR haplotype combinations. The 33.3%
antibiotic therapy phenotype was the least common, representing only VWHKH x
VWHRR cows with N=6 cows. Association analyses identified a total of 7 SNPs
associated with the antibiotic therapy phenotype (Table 6 and Figure 18). Three of the
identified SNPs were highly significant (p < 1.95x10-5) and 4 were suggestively
significant (p = 1.95x10-5 to 9.34x10-5). The identified SNPs spanned 4 chromosomes,
with 1 SNP on each BTA 7 (rs41612889) and BTA 8 (rs109792349), 3 SNPs on BTA 16
(rs41660125, rs41576666, rs41596554) and 2 SNPs on BTA 2 (rs43317360,
rs41644229). One SNP on BTA 2, rs43317360, is located within the CRYBA2
(crystallin beta A2) gene.
Discussion
The goal of this study was to identify genes in linkage disequilibrium with SNPs in
CXCR1 and could be serving as markers for and to identify genes that could be working
pleiotropically with CXCR1 located throughout the genome. These loci of interest could
help explain the different phenotypes observed with respect to inflammation indicators,
S. uberis CFU, and the need for antibiotics to clear the infection from our prior study by
providing candidate genes for further investigation (Siebert 2013). Both approaches to
identify genes were successful and a total of 21 candidate genes were identified and
are discussed below.
Candidate Loci in LD with CXCR1:
The linkage analysis identified 2 separate blocks encompassing the previously
identified CXCR1 SNPs on BTA 2. Block 413 did not include any candidate genes that
were in linkage disequilibrium (LD) with the CXCR1 SNPs. However, block 414
included 22 candidate genes that are in LD with two CXCR1 SNPs. Since these genes
are in LD with the CXCR1 3’ SNPs rs211042414 and rs208795699 previously
associated with phenotypic differences following S. uberis challenge, the CXCR1 SNPs
could be markers for the functions of these candidate genes. Several of these
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Table 5: Frequency of haplotype combinations observed in our sample population and
their corresponding antibiotic therapy groupings.
Haplotype Combination
VWHRR x VWHRR
VWHKH x VWHRR
AWQRR x VWHRR
AWQRR x VWHKH
AWQRR x AWQRR
Total

Frequency
5
7
6
9
11
38

Antibiotic Therapy
Phenotype
100%
33.3%
100%
70-75%
70-75%
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Table 6: Identified loci associated with the CXCR1 antibiotic therapy phenotype.
rs

Locus
1
(chr: bp)

SNP type

Allele
2
frequencies

Nearest gene(s)

Prior evidence

P-value

Loci with prior evidence
rs41660125

16: 10389306

intergenic

A: 0.45
G: 0.55

LOC100848559, CDC73

PL QTL
(Zhang et al., 1998)

1.30x10

-5

rs41576666

16: 9941492

intergenic

C: 0.61
T: 0.39

LOC100848559, CDC73

PL QTL
(Zhang et al., 1998)

3.70x10

-5

rs41596554

16: 10740538

intergenic

G: 0.50
T: 0.50

LOC100848559, CDC73

PL QTL
(Zhang et al., 1998)

9.36x10

-5

--

2.20x10

-6

--

1.54x10

-5

--

2.75x10

-5

--

3.74x10

-5

Newly identified loci
A: 0.70
CRYBA2
C: 0.30
C: 0.65
rs41644229
2: 107681700
5' upstream
LOC101906201
T: 0.35
C: 0.45
rs41612889
7: 107527276
5' upstream
EFNA5
T: 0.55
A: 0.61
rs109792349
8: 8618532
intergenic
LOC783359, PRSS55
T: 0.39
1
Reported positions are based on the Bos taurus UMD_3.1.1 (GCF_000003055.6) genome build.
2
Allele frequencies are representative of the current study population.
rs43317360

2: 107657675

intron variant
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20

18
N=18

Number of Cows

16
14
12
10
8

N=10

6
N=6

4
2

0
100%
70-75%
33%
Antibiotic Therapy Phenotype
Figure 17: Number of cows per antibiotic therapy phenotype grouping.
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Figure 18: Manhattan plot of GWAS for antibiotic therapy phenotype using
BovineSNP50 v2 BeadChip (Illumina, San Diego, CA) in Holsteins (N = 35). The x-axis
shows chromosome and SNP order within a chromosome. The y-axis show the –
log10(P-value) for each SNP. P-value thresholds are indicated by dashed lines: top
black line p = 1.95x10-5; bottom gray line p = 9.34x10-5.
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candidate genes have functions that could be linked to S. uberis pathogenesis or
immune processes.
The ARPC2 (actin related protein 2/3 complex, subunit 2) gene is a subunit of the
ARP complex. The ARP complex is implicated in the control of actin polymerization
within cells, which is critical for a variety of cellular processes including cell motility and
cell-to-cell adhesion (DeMali et al. 2002; Goley and Welch 2006; Pollard and Borisy
2003; Weiner et al. 1999). Alterations in a cow’s cell’s ability to migrate and adhere to
other cells could alter its ability to respond to an infection state since the recruitment of
neutrophils to the site of infection is heavily dependent on both actions and could
explain the differences in phenotype observed following our S. uberis challenge.
Another gene in LD with CXCR1 3’ SNPs rs211042414 and rs208795699 is
GPBAR1 (g-protein coupled bile acid receptor 1) which is the cell surface receptor for
bile acids. Links between GPBAR1 and macrophage function have been established by
applying agonists where such agonists have resulted in reduced monocyte adhesion to
endothelial cells and decreased production of pro-inflammatory cytokines shifting
monocyte conversion to primarily M2 macrophage-like anti-inflammatory cells
(Högenauer et al. 2014; Kida et al. 2013). Alterations in monocyte and macrophage
function in an infection state could alter a cow’s ability to clear an infection and influence
the intensity of the inflammatory response initiated in response to bacteria presence as
observed following our S. uberis challenge.
AAMP (angio-associated migratory cell protein) is another gene in LD with
CXCR1 3’ SNPs rs211042414 and rs208795699 that is part of the immunoglobulin
superfamily (Beckner et al. 1995). AAMP plays a role in the formation of endothelial
tube formation and is associated with angiogenesis, but can also activate NFĸB
(Beckner et al. 2002; Beckner and Liotta 1996; Bielig et al. 2009). NFĸB is a
transcriptional activator of numerous genes including many that are critical for
inflammation and immunity (Bonizzi and Karin 2004). Decreased transcriptional
activation of genes critical for inflammation and immunity could result in a diminished
response to bacteria presence and allow for S. uberis continued growth as observed in
the varying responses to our challenge.
TMBIM1 (transmembrane BAX inhibitor motif containing 1) is also in LD with
CXCR1 3’ SNPs rs211042414 and rs208795699 and is associated with extrinsic
apoptosis regulation and negative regulation of MMP9 (Xu and Reed 1998; Zhao et al.
2006). MMP9 is required for macrophage migration necessary for invading pathogen
elimination (Gong et al. 2008). Reductions in extrinsic apoptosis and macrophage
migration could result in a diminished immune response to invading pathogens leading
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to lower inflammation observed and allowing continued pathogen growth as observed in
the responses to our S. uberis challenge (Siebert 2013).
Another gene in LD with CXCR1 3’ SNPs rs211042414 and rs208795699 is
SLC11A1 (solute carrier family 11 – proton-coupled divalent metal ion transporter).
SLC11A1 is a member of the proton-coupled divalent metal ion transporters that
transports iron, zinc, and manganese cations that is localized to late lysosomes and
endosomes (Goswami et al. 2001; Gruenheid et al. 1997; Searle et al. 1998).
Additionally, SLC11A1 has been implicated in disease resistance through cation control
in macrophages which protects macrophages from their own ROS generation and
sequesters cations that pathogens could use to produce protective enzymes as
reviewed by Blackwell et al. (2001). Thus, SLC11A1 could play a role in a cow’s ability
to properly clear S. uberis following challenge through proper macrophage function.
The VIL1 (villin 1) gene is also in LD with CXCR1 3’ SNPs rs211042414 and
rs208795699 and is a calcium regulated actin binding protein within the cytoskeleton
(Bretscher and Weber 1980). Expression of VIL1 has been observed in the leading
edge of lamellipodia implying a regulating role in actin remodeling needed for cell
migration and it has been demonstrated to regulate apoptosis by maintaining
mitochondrial integrity (Nusrat et al. 1992; Wang et al. 2008). Thus, alterations in VIL1
function could influence the immune response to invading pathogens, specifically the
ability of immune cells to migrate to the site of infection and survive long enough to
eliminate the pathogen which could explain the differences we observed post S. uberis
challenge.
PLCD4 (phospholipase C delta 4), another gene in LD with CXCR1 3’ SNPs
rs211042414 and rs208795699, is a member of the delta class of phospholipase C
enzymes which hydrolyzes PIP2 (phosphatidylinositol 4,5-bisphosphate) to make DAG
(diacylglycerol) and IP3 (inositol 1,4,5-triphosphate) (Ochocka and Pawelczyk 2003).
The production of these secondary messengers is the first step of the arachidonic acid
pathway that is responsible for the production of leukotrienes, thromboxanes,
prostaglandins, and lipoxins which have an array of roles in inflammation, where
alterations in their production could result in different responses to invading pathogens.
The last gene in LD with CXCR1 3’ SNPs rs211042414 and rs208795699 is
RNF25 (ring finger protein 25) which interacts with the p65 subunit of NFĸB to support
transcription (Asamitsu et al. 2003). As discussed with AAMP above, decreased
transcriptional activation of inflammation and immunity genes could result in diminished
response to invading bacteria allowing growth to continue as observed in response to
our S. uberis challenge. Thus, the identification of the haplotype block surrounding the
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bovine CXCR1 gene has provided several potential candidate genes that the CXCR1 3’
SNPs rs211042414 and rs208795699 could be serving as markers for and could be
influencing the phenotypic differences observed following our S. uberis challenge.
Furthermore, there are an additional 13 genes in this block that are either
uncharacterized or do not have a documented link to inflammation, immunity, or
transcriptional regulation that should be further investigated to determine if they could
play a role in S. uberis pathogenesis.
Candidate Loci Associated with Antibiotic Therapy Groupings:
To determine if there were other genes throughout the bovine genome that could
be working pleiotropically with our CXCR1 SNPs or the loci in LD with the CXCR1 SNPs
to cause the phenotypic differences observed following our S. uberis challenge, we
performed an association analysis. The phenotype used grouped cows based on both
CXCR1 haplotype combination and that haplotype combination’s need for antibiotics to
clear S. uberis from the gland. This association analysis identified a total of 7 SNPs.
None of these identified SNPs are within the CXCR1 haplotype blocks discussed above,
but one SNP (rs43317360) was identified on BTA 2 just 0.28 Mb outside of the CXCR1
haplotype block 414. While the identified SNPs themselves may not be causal but
rather in linkage disequilibrium is the causal variant, they do provide several interesting
candidate genes based on the genes they are located within. This SNP (rs43317360) is
an intron variant in the CRYBA2 (crystallin beta A2) gene. Crystallins are the major
structural component of the eye ocular lens but are also implicated in retinal ganglion
cell axonal regeneration following injury (Piri et al. 2013). Additionally, another
crystallin, CRYBB2, has been implicated in promoting neurite activity, demonstrating
roles in tissues besides eyes (Liedtke et al. 2007). The possibility exists that CRYBA2
could play a role in tissue regeneration following injury in other tissues such as the
mammary gland and contribute to resolving the infection state following S. uberis
challenge. This could allow cows to clear the infection more readily leading to the
demonstration of reduced mammary and milk scores. Since highly inflammatory
mammary and milk scores were used as the basis for antibiotic therapy administration,
and CRYBA2 could help explain the variation observed in antibiotic therapy groupings
based on CXCR1 haplotype combination following our S. uberis challenge.
Also of interest, the 3 associated SNPs on BTA 16 (rs41660125, rs41576666,
rs41596554) are within a productive life QTL (Zhang et al. 1998). Productive life refers
to the length of time a cow remains in the herd producing milk, which can be affected
my many factors including health, fertility, and milk yield (Roxström and Strandberg
2002). Cows with phenotypes indicating they can mount an effective immune response
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to invading pathogens and clear the infection without the aid of antibiotic therapy (i.e.:
33% antibiotic therapy phenotype; VWHKH x VWHRR cows) would be more likely to be
retained in the herd, barring other issues, because they would be less labor intensive
and cost producers less money in treatment then cows with the other phenotypes.
In conclusion, this study successfully identified an array of candidate genes that
could help explain the phenotypic differences observed following S. uberis challenge
either because they are in LD with the CXCR1 SNPs or because they are associated
with the antibiotic therapy groupings developed with the cow’s CXCR1 genetic
backgrounds. Many of these candidate genes have roles in immunity, inflammation, or
the regulation of gene expression. Further investigation of these candidate genes
should determine their expression levels in the mammary gland and could help identify
potential preventative or novel treatment compounds for S. uberis mastitis. Additionally,
these results could discover better defined or more accurate genetic markers for
selecting cows with less susceptibility to S. uberis mastitis.
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Abstract
Mastitis, inflammation of the mammary gland, is a devastating disease for the
dairy industry causing billions in lost revenues annually and decreasing milk quality.
Due to prevalence and impacts of mastitis, improved prevention and treatment protocols
are a consistent goal of the industry. S. uberis is a common mastitis pathogen whose
growth in milk is influenced by stage of lactation. The IL-8 receptor, CXCR1, has
demonstrated importance for mastitis and SNPs within CXCR1 have been associated
with mastitis and neutrophil migration. A prior S. uberis intramammary challenge study
demonstrated Holsteins with different CXCR1 haplotype combinations display varying
phenotypes with respect to inflammation indicators and S. uberis counts suggesting
CXCR1 haplotype combination could influence the ability or rate of S. uberis to grow in
milk and the recruitment of leukocytes to the mammary gland. To test this, we collected
aseptic milk samples from cows with differing CXCR1 genetic backgrounds within 7
days post-calving and inoculated them in vitro with 3 strains of S. uberis. Additionally,
leukocyte profiles were evaluated in the aseptic milk samples using the QScout®
platform to determine if CXCR1 haplotype combination influenced total leukocyte
recruitment or type of leukocytes recruited to the mammary gland. Results indicate that
both CXCR1 haplotype combination and S. uberis strain influence the rate of S. uberis
in milk (p < 0.0001). VWHRR x VWHRR milk had the highest rate of S. uberis growth
(slope = 0.58) and AWQRR x AWQRR milk had the lowest rate of S. uberis growth
(slope = 0.098). The highest rate of S. uberis growth was observed from strain UT366
(slope = 0.58) and the lowest rate of growth was observed from strain UT387 (slope =
0.17). CXCR1 haplotype combination did not influence total leukocyte counts or
percentages of leukocyte subpopulations observed in milk (p > 0.05). These results
indicate that both CXCR1 haplotype combination and S. uberis strain virulence
influence S. uberis growth rate in milk which could indicate that concentration of an
inhibitory or permissive factor towards S. uberis growth in milk differs depending on cow
CXCR1 haplotype combination. Future proteomics studies would be beneficial in
identifying any potential factors of interest and lead to the development of novel
preventative or treatment compounds towards S. uberis mastitis.
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Introduction
Mastitis, the inflammation of the mammary gland, is typically caused by bacteria
invading the mammary gland. Impacts of mastitis include dramatic decreases in milk
quality and farm revenues (Fetrow 2000; Klei et al. 1998; Ma et al. 2000).
Streptococcus uberis is a common mastitis pathogen which is commonly isolated from
the mammary gland during the non-lactating period and accounts for a high percentage
of clinical and subclinical mastitis (Bradley et al. 2007; Petrovski et al. 2011; Verbeke et
al. 2014). S. uberis originates in the environment of the cow (i.e.: soils), but can be
passed from cow-to-cow in a contagious manner (Zadoks 2007), making it a large
proportion of the mastitis problem dairy producers combat.
In order for mastitis to occur, invading pathogenic bacteria must be able to
survive and proliferate within the mammary gland by overcoming the host defenses.
The host defenses in the mammary gland are numerous and milk contains a variety of
anti-microbial factors that inhibit pathogen growth (Oliver and Calvinho 1995). Prior
work on growth of S. uberis in mammary secretions has focused stage of lactation.
Periods of intense physiological change demonstrate greater susceptibility to S. uberis
(Jayarao et al. 1999). Secretions obtained during any stage of mammary gland
involution (the period when the mammary gland undergoes shrinkage and tissue
remodeling after lactation cessation) or the dry (non-lactating) period support S. uberis
growth better than secretions obtained during lactation (Oliver 1991; Todhunter et al.
1985). The differences in growth of S. uberis observed during periods of intense
physiological change were attributed to concentrations of antimicrobial factors (i.e.:
lactoperoxidase) and or essential nutrients (i.e.: plasminogen degradation by-products)
needed for S. uberis growth, where secretions obtained during lactation had more
antimicrobial factors or less essential nutrients and supported less S. uberis growth
(Kliem and Hillerton 2002; Leigh 1993; Todhunter et al. 1985). However, when
considering only phases when the mammary gland is actively lactating, early lactation
better permits S. uberis growth than mid or late lactation (Rambeaud et al. 2004). Early
lactation being a highly susceptible period for S. uberis mastitis was supported by the
observation of a 100% infection rate in N=40 Holstein cows in an intramammary
experimental challenge administered within three days post-calving (Siebert 2013).
Early lactation supporting S. uberis growth more than mid or late lactation contradicts
that essential nutrients could be driving differences in S. uberis growth. Plasminogen
concentrations increase as lactation progresses meaning more available nutrients to
promote S. uberis growth, which would dictate more S. uberis growth in later lactation
not less (Benslimane et al. 1990). This suggests there is another mechanism that is
capable of influencing S. uberis growth in milk during lactation.
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Studies have demonstrated that the IL-8 receptor, CXCR1, plays a critical role in
the defense of the mammary gland by influencing neutrophil migration, survival, calcium
signaling, and reactive oxygen species (ROS) generation (Rambeaud et al. 2006;
Rambeaud and Pighetti 2007; Rambeaud and Pighetti 2005). Additionally,
polymorphisms in the CXCR1 gene sequence have been linked to mastitis incidence
(Galvão et al. 2011; Grosse et al. 1999; Leyva-Baca et al. 2008; Verbeke et al. 2012;
Youngerman et al. 2004). A recent S. uberis intramammary challenge study
demonstrated that Holstein cows (N=40) with different CXCR1 haplotype combinations
(Pighetti et al. 2012) displayed varying phenotypes with respect to S. uberis counts,
inflammation indicators, and antibiotic therapies (Siebert 2013). The differing
phenotypes observed following intramammary challenge could indicate that a cow’s
CXCR1 haplotype combination influences the ability or rate of S. uberis to grow in milk
and/or the recruitment of leukocytes to the mammary gland. To test this, we collected
aseptic whole milk from non-infected cows with different CXCR1 haplotype
combinations and inoculated them with three strains of S. uberis obtained from mastitic
cows to monitor growth rates for 12 hours in a laboratory setting. Additionally, leukocyte
profiles were evaluated in the aseptic milk samples using the QScout® platform to
determine if CXCR1 haplotype combination influenced total leukocyte recruitment or
type of leukocytes recruited to the mammary gland.
Materials and Methods
Haplotyping
Blood samples (N=1 for each cow), collected during the dry period via coccygeal
vein puncture, were obtained from all cows expected to calve at Little River ETREC
dairy. Blood was used to isolate DNA with UltraClean BloodSpin DNA Isolation Kit (Mo
Bio, Carlsbad, CA). The SNP containing portion of the CXCR1 gene was amplified as
follows: 1-2 ng of bovine genomic DNA was used as template in a 25 µl reaction
containing specific primers (Forward: 5’-CTTCATC-TTCCGGTGAGGCCTATCAAC-3’;
Reverse: 5’-AAGGGAAGGGGACTTTCCTGGCTG-3’) and Eppendorf HotMaster Mix
(Eppendorf North America; Westbury, NY) according to manufacturer's guidelines. DNA
concentration was confirmed via spectrophotometry using NanoDrop 1000 (Thermo
Fisher Scientific; Wilmington, DE). Conditions for amplification were: an initial hot-start
denaturation at 94oC for 2 min, followed by 50 cycles of 94oC denaturation for 15 s,
62oC annealing for 20 s, and 72oC extension for 60 s. After the last cycle, a 10 min final
extension step at 72oC was added before reactions were chilled to 4oC. Amplified
products were purified to remove primer and excess nucleotides. The resulting purified
CXCR1 DNA was sequenced using bovine CXCR1 specific primers (Forward: 5’111

CTTCATC-TTCCGGTGAGGCCTATCAAC-3’; Reverse: 5’AAGGGAAGGGGACTTTCCTGGCTG-3’) and the CXCR1 haplotype, comprised of
positions +365 (rs211042414), +621 (rs135751317), +735 (rs208795699), +980
(rs43323012), and +995 (rs43323013), was determined based on nucleotide expression
at tagSNP positions +621 (rs135751317), +735 (rs208795699), +816 (rs210501501),
and +980 (rs43323012) in the CXCR1 gene previously identified using phasing on a
larger population (Pighetti et al. 2012; Stephens and Scheet 2005; Stephens et al.
2001). Not all haplotypes combinations were enrolled in the study because of infection
status prior to milk inoculation.
Milk Sampling and Collection
Between two and three days post-calving, aseptic quarter samples were taken
from each cow. Samples were kept on ice and transported back to the lab. One mL of
each sample was plated on an individual blood agar plate using flame sterilized hockey
sticks under a sterile hood. Plates were allowed to completely dry under the hood, then
inverted and place in an incubator at 37°C, 5%CO2 for 48 hrs. Cows with two or more
plates showing no bacteria growth after incubation were chosen to proceed to the milk
inoculation. Composite, aseptic, 100 mL inoculation samples were collected between 4
and 6 days post-calving. An aliquot of the aseptic milk sample was used to determine
the types of leukocytes present in milk using two methods. First, overall somatic cell
counts (SCC) were determined using a benchtop DeLaval Cell Counter DCC (DeLaval,
Kansas City, Missouri). The DeLaval SCC was used as a final screening measure,
where cows with SCC above 200,000 cells/mL (industry standard division point
indicating an intramammary infection), were excluded from milk inoculation protocols
even though their initial microbiology screening two days prior indicated they did not
have an infection. Samples that passed the SCC screening were kept on ice and
transported back to the lab. Prior to inoculation, samples were partitioned into 4 20mL
aliquots (1 for each of the 3 strains and a negative) and warmed to 37°C for 30 mins.
After pre-warming, 1mL of the negative sample was plated on a blood agar plate to
determine if any infection occurred between screening and inoculation sample collection
or if contamination occurred.
Evaluation of Leukocytes in Milk
The aliquot of the aseptic milk used for inoculation was used to determine the
types of leukocytes present in the milk using QScout® MLD platform (Advanced Animal
Diagnostics, Morrisville, NC). QScout® MLD utilizes special cartridges, where 10μL of
the milk sample is loaded onto the cartridge which is inserted into the machine. The
resulting data includes a total leukocyte count (TLC) which is equivalent to a SCC, as
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well as counts and percentages for 3 specific leukocyte populations per microliter
(neutrophils, lymphocytes, and macrophages).
S. uberis Cultures
Frozen stock cultures of 3 strains of S. uberis (UT366, UT387, and UT888) were
obtained from the Tennessee Quality Milk Lab. Stocks were used to inoculate 25 mL of
Todd Hewitt Broth (THB) and cultures were grown at 37°C, 5%CO2 for 24 hrs.
Resulting cultures were used to make 50μL aliquots that were frozen at -80°C. One
fresh aliquot for each strain was used for each inoculation.
Two days prior to milk inoculation, the 50μL aliquots are thawed to room
temperature then plated on a blood agar plate, one plate per strain, using streak
technique. Streak plates were grown at 37°C, 5%CO2 for 24 hrs. After incubation, for
each strain, a sterile loop was used to select 3 individual colonies and then inoculate a
pre-warmed, 15mL aliquot of THB which was incubated overnight at 37°C, 5%CO2. The
next morning, 3 hours prior to milk inoculation, overnight cultures were removed from
the incubator, vortexed, and then 500μL were used to inoculate a pre-warmed 5mL THB
aliquot. New aliquots were incubated at 37°C, 5%CO2 for 3 hrs, and then serially diluted
to approximately 1,000 CFU/mL. Four hundred μL of the diluted culture for each strain
was then used to inoculate the 20mL, pre-warmed milk aliquot for each cow.
Additionally, 100μL of the diluted cultures was plated on Todd Hewitt agar (THA) to
determine actual CFU inoculated for each strain, which was used as the time zero CFU
for each strain’s growth curve.
Inoculating Milk with S. uberis
The diluted S. uberis culture for each strain (400μL) was added to the
corresponding pre-warmed 20mL milk sample. Milk cultures were then vortexed and
placed in the incubator at 37°C, 5%CO2 for 12 hrs. At the start of each hour, samples
were removed from the incubator, vortexed, and 1mL was plated using a flame
sterilized hockey stick to determine how strain growth progressed. After time point, milk
cultures were also serially diluted to ensure colonies were sparse enough to count.
Inoculated milk samples were plated on THA and the negative sample was plated on
blood agar. Plates were allowed to dry completely in the hood, inverted, and then
placed in an incubator at 37°C, 5%CO2. After 48 hrs of incubation, plates were
removed and colonies of S. uberis were counted and used to determine total CFU
present in milk at each time point for each strain.
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Statistical Analysis
A mixed model analysis of variance tested the fixed effects of CXCR1 haplotype
combination, strain, and time and their interactions. The random effect of cow nested
within CXCR1 haplotype combination was also included to account for unknown
variation that an individual’s background and physiology may have introduced into the
model. Time was declared as repeated measures since time point samples were
collected from the same inoculated milk sample. Missing time points were due to
colonies on plates being too numerous to count or because plate contamination was
observed that made counting colonies of S. uberis impossible. Time points 7, 11, and
12 were removed due to > 50% missing data points. The same model was also used to
determine if slopes of S. uberis growth over time differed between CXCR1 haplotype
combinations and strains of S. uberis by including significant interaction terms as fixed
effects directly. Data was log10 transformed in order to maintain normality. Additionally,
QScout® MLD data was utilized to determine if leukocyte populations differed
dependent on CXCR1 haplotype combination, where the model tested the fixed effect of
CXCR1 haplotype combination only, but still included the random effect of cow nested
within CXCR1 haplotype combination to account for unknown variation that an
individual’s background and physiology may have introduced. Analyses were
performed in SAS (v 9.4, Cary, NC) where significance was declared at p < 0.05, and a
trend was declared at p = 0.05 to p = 0.1.
Results
The dominant haplotype combination of the inoculated cows was AWQRR x
VWHRR, which represented 42.9% of cows. The second most frequent haplotype was
homozygous AWQRR representing 33.3% of cows. The remaining two haplotype
combinations (VWHRR x VWHRR, VWHKH x VWHRR) represented much smaller
percentages of the inoculated cows (Table 7). Cows with haplotype combination
VWHKH x AWQRR were not observed.
S. uberis growth was significantly influenced by strain (p < 0.0001) (Figure 19).
Strain 888 grew the most (200.1 ± 178.5) but was statistically similar to strain 366 (70.8
± 61.4 CFU). Strain 366 was also similar to strain 387 (11.7 ± 10.2 CFU). All strains
were statistically unique from the negative (0.07 ± 0.06 CFU). Additionally, the
interaction of strain and time was significant (p < 0.0001) indicating the rate of growth
over time differed across the strains (Figure 20). Strain 366 had the greatest slope,
0.58 CFU/hr. indicating the quickest rate of growth over time. Strain 888 had the
second largest slope, 0.31 CFU/hr., followed by strain 387 with a slope of 0.17 CFU/hr.
The smallest slope was observed by the negative, and it actually showed a decrease in
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Table 7: Frequency of haplotype combinations observed in cows whose milk was
inoculated with the 3 strains of S. uberis.
Haplotype Combination
VWHRR x VWHRR
VWHKH x VWHRR
AWQRR x VWHRR
AWQRR x AWQRR
Total

Frequency
2
3
9
7
21

Percent
9.5
14.3
42.9
33.3
100
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Figure 19: Growth of three strains of S. uberis, represented as back transformed least
squares means from log10, in aseptic whole milk obtained from Holstein cows within 7
days post-calving. Letters above the bars indicated means that differ (p < 0.0001).
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366
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Figure 20: The effect of S. uberis strain on growth over time in aseptic whole milk
obtained from Holstein cows within 7 days post-calving. All slopes differed from each
other significantly over time (p < 0.0001).
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growth over time with a slope of -0.16.
S. uberis growth was not influenced by haplotype combination (p = 0.668), nor
was a strain by haplotype combination interaction observed (p = 7879). However, the
interaction of haplotype combination and time was significant (p < 0.0001) indicating the
rate of S. uberis growth over time differed across haplotype combinations (Figure 21).
VWHRR x VWHRR milk samples grew the fastest with a slope of 0.58 CFU/hr.
AWQRR x AWQRR milk samples grew the slowest with a slope of only 0.098 CFU/hr.
VWHKH x VWHRR and AWQRR x VWHRR milk samples had intermediate slopes at
0.41 and 0.21 CFU/hr. respectively.
Haplotype combination did not influence total leukocyte counts collected using
the QScout® MLD platform (p = 0.6424) (Figure 22). Haplotype combination also did
not influence the percentages of neutrophils (p = 0.1509), lymphocytes (p = 0.7863), or
macrophages (p = 0.4903) observed in the aseptic milk collected (Figure 23). However,
for all haplotype combinations, neutrophils were the majority of leukocytes present (6050%) with lymphocytes and macrophages each representing smaller fractions (15-30%
each) (Figure 23).
Discussion
The present study determined that CXCR1 haplotype combination influences the
rate that S. uberis growth in whole milk. These results are consistent with results from
our prior S. uberis intramammary challenge study that demonstrated cows with differing
CXCR1 haplotype combinations showed differing S. uberis CFU in the gland postchallenge (Siebert 2013). The VWHRR x VWHRR displayed the highest overall S.
uberis CFU in the challenge study and had the highest rate of S. uberis growth in the
present study suggesting S. uberis most easily grows in VWHRR x VWHRR milk. The
challenge study identified AQWRR x VWHRR as the haplotype combination with the
least amount of S. uberis growth and in the present study this combination had the
second smallest rate of S. uberis growth in milk. Combined this suggests that the
AWQRR allele better permits S. uberis growth than the VWHRR allele. This is further
confirmed by the AWQRR x AWQRR milk displaying the overall lowest S. uberis rate of
growth in the present study. The VWHKH x VWHRR milk displayed an intermediate
rate of S. uberis growth in the present study and had overall S. uberis CFU similar to all
other haplotype combination in the challenge study suggesting the VWHKH allele
supports growth of S. uberis better than AWQRR but not as well as VWHRR.
The differences in S. uberis growth based on CXCR1 haplotype combination
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VWHKH x VWHRR
VWHRR x VWHRR
AWQRR x VWHRR

AWQRR x AWQRR

Figure 21: The effect of haplotype combination on S. uberis growth over time in aseptic
whole milk obtained from Holstein cows within 7 days post-calving. All slopes differed
from each other significantly over time (p < 0.0001).
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Figure 22: Total leukocyte counts observed for each haplotype combination based on
QScout analysis performed on aseptic whole milk obtained from Holstein cows within 7
days post-calving. Haplotype combination did not influence total leukocyte counts p =
6424.
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Figure 23: Percentages of leukocyte sub-populations observed for each haplotype
combination based on QScout analysis performed on aseptic whole milk obtained from
Holstein cows within 7 days post-calving. Haplotype combination did not influence the
percentages of neutrophils (p = 0.1509), lymphocytes (p = 0.7863), or macrophages (p
= 0.4903) observed.
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could be due to differences in neutrophil ability. The middle position of the haplotype
(amino acid position 245, SNP 735, rs208795699) is associated with the ability of
neutrophils to migrate and survive as well as internal calcium signaling and reactive
oxygen species (ROS) generation (Rambeaud et al. 2006; Rambeaud and Pighetti
2007; Rambeaud and Pighetti 2005). Where VWHRR x VWHRR cows would be less
capable of recruiting neutrophils to the site of infection and have better killing ability
compared to AWQRR x AWQRR cows. However, the QScout® MLD analysis
conducted in the present study did not show that the percentages of neutrophils differed
across haplotype combinations. Furthermore, S. uberis has demonstrated the ability to
evade neutrophil killing in vitro, but is effectively killed by macrophages suggesting the
percentage of macrophages could be more important for S. uberis clearance from the
mammary gland (Oliver et al. 1998a). But the present study also demonstrated that the
percentage of macrophages present in milk did not differ based on haplotype
combination, suggesting other mechanisms may be at work. Of interest, since the
present study was conducted in vitro where introduction of S. uberis occurred once milk
was removed from the cow, differences in S. uberis clearance by neutrophils and
macrophages would rely on leukocytes present in the milk at the time of collection since
the ability to recruit more leukocytes is irrelevant.
Variation in proteomic profiles of milk could influence a cow’s ability to clear S.
uberis from the mammary gland. Proteomics studies of bovine milk and its fractions
(i.e.: exosomes, whey, milk fat globule membranes) have identified many components
that can influence the immune response to invading pathogens (Ibeagha-Awemu et al.
2010; Reinhardt and Lippolis 2006; Reinhardt and Lippolis 2008; Reinhardt et al. 2012;
Reinhardt et al. 2013; Smolenski et al. 2014). Milk fat globule membranes and
exosome milk fractions contain immune components that are essential for the detection
of infection and for proper immune response to infection (Reinhardt and Lippolis 2006;
Reinhardt et al. 2012). Additionally, following Staphylococcus aureus infection, there is
an increase in the components of neutrophil NETs seen in milk fat globule membranes
(Reinhardt et al. 2013). Neutrophil NETs function to trap and bacteria to prevent further
pathogenesis (Brinkmann et al. 2004). Thus, alterations in concentration of any of
these immune components could influence the growth of S. uberis in milk. If levels of
these components essential for fighting off invading pathogens differ based on CXCR1
haplotype combination, they could explain the differences in S. uberis growth rate
observed in the present study. Of note, while these results may prove relevant for the
results we observed, they were reported based on individual milk fractions whereas our
study was conducted using whole milk. Thus, the interactions between all the different
fractions and their components could have an effect on the ability of S. uberis to grow.
Also of interest, a prior study suggested that plasminogen concentration could influence
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growth rate of S. uberis because its degradation is essential for S. uberis to get the
essential nutrients it needs for growth (Kliem and Hillerton 2002). If plasminogen, or
other S. uberis nutrient sources, vary with CXCR1 haplotype combination, haplotype
combinations with higher nutrient source concentrations would better permit S. uberis
growth.
The present study also observed differences in the ability and rate of S. uberis
growth based on S. uberis strain. These findings were consistent with prior findings by
Rambeaud et al. (2004) and are likely due to differences in virulence between S. uberis
strains. Both UT366 and UT888 demonstrated the two highest overall S. uberis growth
in the present study and are known to cause clinical mastitis. Strain UT366 is
associated with the rapid onset of acute clinical systemic symptoms (Doane et al. 1987)
which is supported by its steep rate of S. uberis growth in the present study. The
UT888 strain is associated with milder clinical mastitis and a lag in S. uberis growth
while it adapts to the mammary gland environment (Oliver et al. 2003; Rambeaud et al.
2003) which is supported by its rate of S. uberis growth in the present study being lower
than UT366 but higher than UT387. Furthermore, both UT366 and UT888 have
demonstrated the ability to internalize into host cells via binding lactoferrin, a common
milk protein, and exploiting caveolae mediated endocytosis (Almeida et al. 2010).
However, UT888 has enhanced ability to bind lactoferrin and has higher transcytosis
when compared to UT366 (Almeida et al. 2010), suggesting UT888 has a better ability
to internalize and hide from the immune system than UT366. Better ability to internalize
and hide from the immune system would facilitate lower growth observed in milk as
observed in the present study and the ability of UT888 infections to sometimes persist
for more than one lactation (Oliver et al. 1998b). UT387 displays the lowest rate of S.
uberis growth in the present study likely because it expresses a capsule making growth
and proliferation more time intensive than the other two strains studied which do not
express capsules.
In conclusion, this study provides evidence that S. uberis growth in milk during
early lactation is influenced by both the cow CXCR1 haplotype combination and S.
uberis strain virulence. This could indicate that the concentration of an inhibitory or
permissive factor towards S. uberis growth in milk differs depending on cow CXCR1
45haplotype combination. Conducting a proteomics survey of milk from cows with
differing CXCR1 haplotype combinations could identify any potential compounds of
interest and lead to the development of novel preventative or treatment compounds
towards S. uberis mastitis.
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The objective of this dissertation was to identify genetic associations with unique
mastitis phenotypes developed using data from an experimental intramammary S.
uberis challenge. Data collected following challenge included somatic cell counts
(SCC), S. uberis CFU, mammary scores, milk scores, and antibiotic therapy use
(Siebert 2013), which were used to develop 10 novel phenotypes directly related to S.
uberis mastitis. Association analyses for these novel phenotypes identified 17 SNPs
that are within previously identified quantitative trait loci (QTLs) for mastitis or
phenotypes with links to mastitis (i.e.: productive life, milk yield). Identifying
associations with SNPs in regions with prior evidence linked to mastitis helps establish
the validity of using our novel phenotypes in response to direct, experimental S. uberis
challenge for GWAS. Furthermore, genomic studies with pathogen specificity have
been limited (Sørensen et al. 2008), which has limited the identification of candidate loci
with functions linked to individual pathogens, a gap our S. uberis specific study may
help fill. Additionally, because we identified SNPs in regions with prior evidence for
mastitis or related phenotypes that were not pathogen specific, these SNPs could also
be associated with other causative pathogens. Besides SNPs in regions with prior
evidence, our novel phenotypes were associated an additional 35 SNPs across the
bovine genome.
Identified SNPs have provided an array of candidate genes whose functions
could be linked to the variation in phenotypes observed following S. uberis
intramammary experimental challenge. We identified a total of 23 possible candidate
genes where the majority of identified candidate genes fall into one of two categories:
inflammation/immune response or gene expression regulation. Once bacteria invade
the mammary gland and are recognized by host cells, inflammation is initiated.
Inflammatory cytokines/chemokines then initiate the immune response. The immune
response is controlled by many aspects, but a key regulator is gene transcription, where
bacterial recognition and pro-inflammatory cytokines induce the transcription of other
genes needed for a proper immune response. Therefore, candidate genes associated
with these processes are critical to a cow’s ability to combat invading pathogens within
the mammary gland such as S. uberis.
Of particular interest are two candidate genes: TIAM2 (t-cell invasion and
metastasis-2) identified with the SCC cure phenotype and TRAPPC9 (trafficking protein
particle complex 9) identified with the severity score phenotype. TIAM2 is a guanine
nucleotide exchange factor that functions within small GTPases that has been
implicated in cell invasion, migration, adhesion, and apoptosis in cancers (Chen et al.
2012; Rooney et al. 2010). Since TIAM2 was identified with the SCC cure phenotype,
which grouped cows based on how long post-challenge their SCC returned to a healthy
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level indicating clearance of infection, TIAM2 could play a role in ensuring cells migrate
to the site of infection efficiently following inflection allowing for fast resolution of
infection. TRAPPC9 plays a role in phosphorylating the IKK complex which controls
activation of NFĸB (Hu et al. 2005). NFĸB is a transcriptional activator of many genes
including many that are critical for inflammation and immunity including proinflammatory cytokine/chemokine production and adhesion molecule expression
(Bonizzi and Karin 2004). TRAPPC9 was identified as associated with the severity
score phenotype which summed milk and mammary score for the first 7 days postchallenge. Cows with higher severity scores would have demonstrated more
inflammation following challenge indicating a strong immune response and strong
activation of NFĸB. Further support of this is that a QTL for SCS was identified in this
same region (Kaupe et al. 2007). Strong activation of NFĸB would likely result in better
recruitment of SCC to the infection site because of increased cytokine and adhesion
molecule expression.
Furthermore, prior studies have identified CXCR1 as a gene important for
mastitis (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud and Pighetti
2005; Siebert 2013; Youngerman et al. 2004a; Youngerman et al. 2004b). Additionally,
CXCR1 genetic background has been demonstrated to influence cow response to S.
uberis intramammary challenge (Siebert 2013). However, observed variation in
response to challenge could be attributed to other genes in LD with CXCR1. We
identified the haplotype block surrounding the CXCR1 gene to identify other genes in
LD with the polymorphisms in CXCR1 that are potential candidate genes. Linkage
analysis identified that the CXCR1 SNPs are part of 2 separate haplotype blocks which
also contain 21 candidate genes.
Of particular interest of the candidate genes identified from linkage analysis is the
SLC11A1 (solute carrier family 11 – proton-coupled divalent metal ion transporter;
NRAMP1) located from 107,114,929 – 107,125,854 bp on BTA 2. SLC11A1 is a
member of the proton-coupled divalent metal ion transporters that transports iron, zinc,
and manganese cations that is localized to late lysosomes and endosomes (Goswami
et al. 2001; Gruenheid et al. 1997; Searle et al. 1998). Additionally, SLC11A1 has been
implicated in disease resistance through cation control in macrophages which protects
macrophages from their own ROS generation and sequesters cations that pathogens
could use to produce protective enzymes as reviewed by Blackwell et al. (2001).
Proper macrophage function and killing ability are particularly important for S. uberis
infections S. uberis evades neutrophils, which are the primary phagocytic cell present
following infection of the mammary gland (Oliver et al. 1998). Furthermore, SLC11A1
has been associated with resistance to intracellular pathogens by prohibiting their
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replication and S. uberis has the ability to internalize into host cells (Almeida et al. 2000;
Gruenheid et al. 1997; Tamilselvam et al. 2006). Thus, SLC11A1 could play a role in a
cow’s ability to properly clear S. uberis following challenge.
Lastly, we demonstrated that CXCR1 haplotype combination influences the rate
of S. uberis growth in milk in vitro. Where VWHRR x VWHRR milk supported S. uberis
growth the most and AWQRR x AWQRR milk supported S. uberis growth the least
regardless of S. uberis strain used for inoculation. These two haplotype combinations
differ only at positions 365 and 735 which are the positons demonstrated to be in LD
with SLC11A1. This provides further support that SLC11A1 could be a valid candidate
gene for explaining variation in responses following S. uberis intramammary challenge
and that variation in divalent metal ions, which are controlled by SLC11A1, may
influence the growth rate of S. uberis in milk.
Overall, we have identified many candidate genes, whose functions are primarily
linked to inflammation/immunity and gene regulation. We also have identified that S.
uberis growth rate in milk differs depending on the CXCR1 haplotype combination
expressed by the cow, suggesting concentration of an inhibitory or permissive factor
towards S. uberis growth differs with CXCR1 haplotype combination. Considered
together, our results imply that variation in one of the identified candidate genes could
be influencing the rate of S. uberis growth and thus S. uberis mastitis. Furthermore,
using pathogen specific phenotypes like those generated here could provide an ideal
method for identifying host genes involved in mediating the virulence of S. uberis which
we also demonstrated to be an important factor in the rate of S. uberis growth in milk.
Further investigation of identified candidate genes could lead to the establishment of
more effective or better defined genetic selection methods or uncover novel
preventative or treatment compounds that could be used against S. uberis mastitis.
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Table A- 1: Comprehensive list of SNPs identified using novel phenotypes with distance
to neighboring SNPs and genotype frequencies indicated. Final column indicates status
of the SNP following SNP pruning based on minor allele frequencies.
SNP (rs)

Locus
(Chr: bp)

Dist. to
3'SNP
(bp)

Dist. To
5' SNP
(bp)

rs43273037

1: 134,069,561

38,757

20,683

rs110974478

1: 150,141,293

26,075

27,008

rs43224998

1: 34,903,570

39,073

30,946

rs43317360

2: 107,657,675

40,772

24,025

rs41644229

2: 107,681,700

24,025

24,019

rs41645172

2: 109,778,246

37,402

34,097

rs41619984

2: 132,148,018

54,001

22,137

rs110345656

2: 133,861,562

44,754

27,677

rs41637469

2: 132,404,449

118,720

22,533

rs43499732

3: 6,480,313

36,955

30,339

rs109880729

3: 27,600,325

45,685

41,976

rs109513885

3: 34,263,481

35,397

21,762

rs43709346

3: 74,836,184

91,656

61,282

rs43352862

3: 89,649,212

27,834

26,390

rs43161729

3: 91,379,427

26,464

22,825

rs41615858

3: 91,402,252

22,825

31,407

rs41677930

3: 93,543,745

20,056

45,499

rs41630751

3: 93,589,244

45,499

58,424

rs43715308

3: 115,115,735

22,332

25,008

#
Genotypes

Genotypes
Freqs.

GG: 7
GT: 16
TT: 0
AA: 0
AG: 4
GG: 36
AA: 25
AG: 14
GG: 1
AA: 22
AC: 17
CC: 0
CC: 17
CT: 17
TT: 1
AA: 22
AG: 18
GG: 0
AA: 39
AC: 1
CC: 0
AA: 0
AG: 1
GG: 39
AA: 0
AG: 1
GG: 37
GG: 3
GT: 6
TT: 29
CC: 0
CT: 2
TT: 38
CC: 4
CT: 20
TT: 15
AA: 39
AG: 1
GG: 0
GG: 33
GT: 1
TT: 0
GG: 38
GT: 1
TT: 0
CC: 39
CG: 1
GG: 0
CC: 39
CT: 1
TT: 0
AA: 39
AC: 1
CC: 0
GG: 0
GT: 1
TT: 39

GG: 0.30
GT: 0.70
TT: 0.0
AA: 0.0
AG: 0.10
GG: 0.90
AA: 0.63
AG: 0.35
GG: 0.03
AA: 0.56
AC: 0.44
CC: 0.00
CC: 0.49
CT: 0.49
TT: 0.02
AA: 0.55
AG: 0.45
GG: 0.0
AA: 0.97
AC: 0.03
CC: 0.0
AA: 0.0
AG: 0.03
GG: 0.97
AA: 0.0
AG: 0.03
GG: 0.97
GG: 0.08
GT: 0.16
TT: 0.76
CC: 0.0
CT: 0.05
TT: 0.95
CC: 0.10
CT: 0.51
TT: 0.39
AA: 0.97
AG: 0.03
GG: 0.0
GG: 0.97
GT: 0.03
TT: 0.00
GG: 0.97
GT: 0.03
TT: 0.00
CC: 0.97
CG: 0.03
GG: 0.0
CC: 0.97
CT: 0.03
TT: 0.0
AA: 0.97
AC: 0.03
CC: 0.0
GG: 0.0
GT: 0.03
TT: 0.97
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# Missing

Missing
Freq.

Status

17

0.43

Keep

0

0.00

Keep

0

0.00

Keep

1

0.03

Keep

5

0.13

Keep

0

0.00

Keep

0

0.00

Remove

0

0.00

Remove

2

0.05

Remove

2

0.05

Keep

0

0.00

Keep

1

0.03

Keep

0

0.00

Keep

6

0.15

Remove

1

0.03

Remove

0

0.00

Remove

0

0.00

Remove

0

0.00

Remove

0

0.00

Remove

Table A- 1: Continued
SNP (rs)

Locus
(Chr: bp)

Dist. to
3'SNP
(bp)

Dist. To
5' SNP
(bp)

rs109567359

3: 116,110,288

48,493

21,672

rs41576873

4: 92,742,789

37,598

22,337

rs43423752

5: 2,925,015

79,943

43,556

rs41655875

5: 26,621,180

59,518

39,863

rs41612889

7: 107,527,276

26,324

74,705

rs110556992

7: 65,047,126

36,604

24,768

rs109792349

8: 8,618,532

78,759

33,274

rs42488893

8: 19,967,642

26,627

51,187

rs41665257

9: 4,581,947

33,954

33,076

rs41594141

9: 73,368,179

27,358

49,534

rs109484182

9: 93,183,596

39,525

30,067

rs110216702

9: 100,163,987

25,797

140,058

rs41903759

10: 68,693,555

25,657

28,870

rs109629398

10: 74,011,076

31,092

21,743

rs41610542

11: 7,625,345

39,598

46,097

rs110866336

12: 77,746,796

51,412

69,844

rs109788678

13: 11,784,421

51,340

47,059

rs41565622

13: 24,688,809

43,157

43,307

rs110804434

13: 78,901,415

43,289

26,890

rs110199901

14: 2,524,432

32,876

29,093

#
Genotypes

Genotypes
Freqs.

CC: 31
CT: 1
TT: 0
AA: 16
AG: 18
GG: 3
CC: 39
CT: 1
TT: 0
CC: 0
CT: 2
TT: 24
CC: 4
CT: 18
TT: 9
CC: 10
CT: 20
TT: 4
AA: 17
AT: 16
TT: 5
CC: 12
CT: 16
TT: 1
CC: 0
CT: 3
TT: 32
AA: 14
AG: 22
GG: 2
AA: 9
AG: 18
GG: 8
AA: 27
AG: 12
GG: 0
GG: 0
GT: 1
TT: 37
AA: 39
AG: 1
GG: 0
AA: 28
AG: 10
GG: 1
AA: 28
AG: 11
GG: 0
CC: 22
CT: 11
TT: 5
AA: 9
AG: 25
GG: 5
AA: 0
AG: 7
GG: 3
AA: 10
AG: 17
GG: 12

CC: 0.97
CT: 0.03
TT: 0.0
AA: 0.43
AG: 0.49
GG: 0.08
CC: 0.97
CT: 0.03
TT: 0.0
CC: 0.00
CT: 0.08
TT: 0.92
CC: 0.13
CT: 0.58
TT: 0.29
CC: 0.29
CT: 0.59
TT: 0.12
AA: 0.45
AT: 0.42
TT: 0.13
CC: 0.41
CT: 0.55
TT: 0.04
CC: 0.0
CT: 0.09
TT: 0.91
AA: 0.37
AG: 0.58
GG: 0.05
AA: 0.26
AG: 0.51
GG: 0.23
AA: 0.69
AG: 0.31
GG: 0.00
GG: 0.0
GT: 0.03
TT: 0.97
AA: 0.98
AG: 0.02
GG: 0.0
AA: 0.72
AG: 0.26
GG: 0.02
AA: 0.72
AG: 0.28
GG: 0.0
CC: 0.58
CT: 0.29
TT: 0.13
AA: 0.23
AG: 0.64
GG: 0.13
AA: 0.0
AG: 0.70
GG: 0.30
AA: 0.25
AG: 0.44
GG: 0.31
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# Missing

Missing
Freq.

Status

8

0.20

Remove

3

0.08

Keep

0

0.00

Keep

14

0.35

Keep

9

0.23

Keep

6

0.15

Keep

2

0.05

Keep

11

0.28

Keep

5

0.13

Keep

2

0.05

Keep

5

0.13

Keep

1

0.03

Keep

2

0.05

Remove

0

0.00

Remove

1

0.03

Keep

1

0.03

Keep

2

0.05

Keep

1

0.03

Keep

30

0.75

Keep

1

0.03

Keep

Table A- 1: Continued
SNP (rs)

Locus
(Chr: bp)

Dist. to
3'SNP
(bp)

Dist. To
5' SNP
(bp)

rs55617160

14: 4,468,478

30,211

25,426

rs109427689

15: 25,622,211

86,644

47,186

rs41576666

16: 9,941,492

57,705

39,509

rs41660125

16: 10,389,306

30,896

36,406

rs41596554

16: 10,740,538

37,074

30,430

rs41803475

16: 34,994,367

30,219

29,812

rs29019936

17: 562,366

86,303

85,971

rs41831243

17: 5,221,649

30,026

25,007

rs41570578

17: 64,142,204

92,914

22,597

rs29015249

18: 24,862,274

79,879

35,464

rs109290019

18: 53,260,898

36,260

21,033

rs109070561

18: 53,281,931

21,033

26,408

rs109243453

20: 58,928,800

63,912

22,186

rs41951389

20: 59,627,852

28,119

36,539

rs109961240

20: 63,407,185

27,332

27,944

rs111021268

21: 23,530,389

44,067

81,952

rs42651398

21: 39,716,280

56,906

42,242

rs109417302

21: 58,323,035

23,590

86,031

rs110942101

22: 7,385,040

71,997

35,676

rs109747337

22: 58,790,629

42,027

25,750

#
Genotypes

Genotypes
Freqs.

AA: 3
AG: 18
GG: 14
AA: 4
AC: 25
CC: 4
CC: 19
CT: 12
TT: 8
AA: 5
AG: 20
GG: 11
GG: 7
GT: 18
TT: 7
CC: 39
CT: 1
TT: 0
CC: 2
CT: 26
TT: 8
CC: 0
CT: 3
TT: 32
GG: 20
GT: 10
TT: 3
CC: 1
CT: 20
TT: 17
AA: 14
AG: 18
GG: 6
AA: 6
AG: 20
GG: 11
AA: 6
AG: 16
GG: 17
CC: 6
CT: 19
TT: 14
AA: 3
AG: 14
GG: 22
CC: 38
CT: 2
TT: 0
CC: 0
CT: 27
TT: 1
GG: 19
GT: 1
TT: 0
GG: 0
GT: 3
TT: 37
AA: 37
AG: 3
GG: 0

AA: 0.09
AG: 0.51
GG: 0.40
AA: 0.11
AC: 0.78
CC: 0.11
CC: 0.49
CT: 0.31
TT: 0.20
AA: 0.14
AG: 0.56
GG: 0.30
GG: 0.22
GT: 0.56
TT: 0.22
CC: 0.97
CT: 0.03
TT: 0.0
CC: 0.06
CT: 0.72
TT: 0.22
CC: 0.0
CT: 0.09
TT: 0.91
GG: 0.60
GT: 0.31
TT: 0.09
CC: 0.03
CT: 0.52
TT: 0.45
AA: 0.37
AG: 0.47
GG: 0.16
AA: 0.16
AG: 0.54
GG: 0.30
AA: 0.15
AG: 0.41
GG: 0.44
CC: 0.15
CT: 0.49
TT: 0.36
AA: 0.08
AG: 0.36
GG: 0.56
CC: 0.95
CT: 0.05
TT: 0.0
CC: 0.0
CT: 0.96
TT: 0.04
GG: 0.95
GT: 0.05
TT: 0.0
GG: 0.0
GT: 0.08
TT: 0.92
AA: 0.93
AG: 0.07
GG: 0.0
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# Missing

Missing
Freq.

Status

5

0.13

Keep

7

0.18

Keep

1

0.03

Keep

4

0.10

Keep

8

0.20

Keep

0

0.00

Remove

4

0.10

Keep

5

0.13

Keep

7

0.18

Keep

2

0.05

Keep

2

0.05

Keep

3

0.08

Keep

1

0.03

Keep

1

0.03

Keep

1

0.03

Keep

0

0.00

Keep

12

0.30

Keep

20

0.50

Remove

0

0.00

Keep

0

0.00

Keep

Table A- 1: Continued
SNP (rs)

Locus
(Chr: bp)

Dist. to
3'SNP
(bp)

Dist. To
5' SNP
(bp)

rs109473352

22: 59,325,992

48,161

33,959

rs110693161

24: 48,872,488

87,497

27,307

rs110747207

26: 50,933,887

56,392

19,618

rs110599808

28: 247,173

37,280

61,632

rs41612729

28: 5,052,476

46,198

70,546

rs110196308

28: 7,899,978

21,253

40,207

rs41653441

28: 28,149,081

50,031

36,613

#
Genotypes

Genotypes
Freqs.

CC: 0
CT: 1
TT: 39
AA: 2
AG: 7
GG: 30
AA: 0
AG: 8
GG: 31
AA: 4
AG: 23
GG: 13
AA: 12
AG: 23
GG: 4
AA: 0
AG: 1
GG: 39
CC: 8
CT: 18
TT: 7

CC: 0.0
CT: 0.03
TT: 0.97
AA: 0.05
AG: 0.18
GG: 0.77
AA: 0.0
AG: 0.21
GG: 0.79
AA: 0.10
AG: 0.58
GG: 0.32
AA: 0.31
AG: 0.59
GG: 0.10
AA: 0.0
AG: 0.03
GG: 0.97
CC: 0.24
CT: 0.55
TT: 0.21
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# Missing

Missing
Freq.

Status

0

0.00

Remove

1

0.03

Keep

1

0.03

Keep

0

0.00

Keep

1

0.03

Keep

0

0.00

Remove

7

0.18

Keep
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